cv-stephenvfaraone - bio · guest editor, seminars in medical genetics, schizophrenia issue 1999...

CURRICULUM VITAE NAME: Stephen V. Faraone, PhD ADDRESS: Department of Psychiatry

SUNY Upstate Medical University 750 East Adams St. Syracuse, NY 13210

DATE & PLACE OF BIRTH: July 27, 1956 Babylon, New York EDUCATION:

Date Discipline Degree Institution 1978 Clinical Psychology B.A. State University of New York at Stony Brook 1980 Clinical Psychology M.A. The University of Iowa 1982 Clinical Psychology Ph.D. The University of Iowa 1982-1983 Clinical Psychology Intern Department of Psychiatry and Human Behavior,

Brown University Program in Medicine 1983-1984 Psychiatric Epidemiology

and Genetics Fellow Department of Psychiatry and Human Behavior,

Brown University Program in Medicine ACADEMIC APPOINTMENTS:

Dates Title Department Institution 2003-2004 Professor Psychiatry SUNY Upstate Medical University 2003-2004 Professor Epidemiology Harvard School of Public Health 2002-2004 Clinical Professor Psychiatry Harvard Medical School 1993-2002 Associate Professor Psychiatry Harvard Medical School 1989-1993 Assistant Professor Psychiatry Harvard Medical School 1985-1989 Instructor Psychiatry Harvard Medical School 1984-1985 Assistant Instructor Psychiatry & Human

Behavior Brown University Program in Medicine

OTHER ACADEMIC POSITIONS and MAJOR VISITING APPOINTMENTS:

Dates Title Department Institution 1989-2004 Director of Research Pediatric Psychopharmacology Massachusetts General Hospital 2003 Janssen Visiting Professor Psychiatry University of Nebraska 2001 Pfizer Visiting Professor Psychiatry Stanford University 2004-present Director, Child & Adolescent

Psychiatry Research Psychiatry SUNY Upstate Medical University

2004-present Director Genetics Research SUNY Upstate Medical University

HOSPITAL APPOINTMENTS:

Dates Title Hospital 2002-2004 Senior Scientific Advisor, Pediatric Psychopharmacology

Research Program Massachusetts General Hospital

2002-2004 Psychologist Massachusetts General Hospital 1999-2002 Associate Psychologist Massachusetts General Hospital 1989-1999 Consultant in Psychology Massachusetts General Hospital HONORS AND DISTINCTIONS (Year and name of award):

2005 Elected to Vice Presidency, International Society of Psychiatric Genetics 2003 Book of the Year Award, American Journal of Nursing 2003 Selected to be Visiting Professor at the Norwegian Centre for Advanced Study, Oslo, Norway 2003 Janssen Distinguished Visiting Professor, University of Nebraska 2003 Elected to Board of Directors, International Society of Psychiatric Genetics 2002 Inducted into the CHADD Hall of Fame in recognition of outstanding achievement in medicine

and education research on attention disorders. 2001 Pfizer Visiting Professor, Stanford University 2000 Eighth highest producer of High Impact Papers in Psychiatry (1990-1999) as determined by

the Institute for Scientific Information (Science, 2000, Vol 288, pg 959). This ranking places me as the top ranked psychologist in the world.

1996 Listed in Strathmore’s Who’s Who Registry 1994 Listed in Men of Achievement 1993 Listed in Who’s Who in American Education 1993 Listed in Dictionary of International Biography: The Biographical Record of Contemporary Achievement 1992 Listed in Who’s Who in the East 1985 Listed in Who's Who Among Human Service Professionals 1980 Elected to Sigma Xi 1978 Elected to Phi Beta Kappa 1978-1982 Teaching Research Fellowship, Department of Psychology, The University of Iowa 1978 B.A. with Highest Honors MAJOR PROFESSIONAL SERVICE (e.g. NIH study sections, NSF committees, NAS committees, etc.):

National Service Date(s)

Member, Editorial Board, Journal of Attention Disorders 2005-Present Member, Editorial Board, Journal of Child Psychology & Psychiatry 2005-Present Member, Editorial Board, Biological Psychiatry, 2005-Present Member, Editorial Board, Behavioral and Brain Functions 2004-Present Member, Editorial Board, The Journal of Psychiatric Medicine 2004-Present Chair, Society of Biological Psychiatry’s Neuroscience of ADHD Meeting 2004 Guest Editor, Primary Psychiatry 2004 Guest Editor, Seminars in Medical Genetics, Bipolar Disorder Issue 2003 Member, Advisory Board, National Alliance for Advancement of ADHD Care 2002-Present Associate Editor for Statistics & Methodology, Journal of Child & Adolescent 2001-Present Psychopharmacology Member, Advisory Board for CME program: Examining New Advances 2001 in the Diagnosis and Management of ADHD Medical Education Systems Member, Expert Consensus Panel for ADHD, Journal of Attention Disorders 2001

Member, Advisory Board for CME program: Advancing the Cornerstone 2001 of ADHD Therapy, Strategic Implications Member, Advisory Board for Fibromyalgia Research, Cypress BioScience 2001 Member, Advisory Board for CME program: ADHD and Its Comorbidities 2001 Colwood Health World Alza Pharmaceuticals Member, Panel of Biostatistical and Methods, Journal of the American Academy 2000-Present of Child and Adolescent Psychiatry Consultants Member, Adult ADHD Advisory Board, Alza Pharmaceuticals 2000 Ad Hoc Member, Genome Review Committee, National Institute of Health 2000 Co-Editor, Neuropsychiatric Genetics 1999-Present Co-Editor, Psychiatry Section, Best Practice of Medicine 1999-2001

National Service Date(s)

Guest Editor, Seminars in Medical Genetics, Schizophrenia Issue 1999 Co-Editor, Psychiatry Section, Current Practice of Medicine 1999-2001 Group Member, Advisory Board, Psychiatric Genetics Program 1999 Education Program & Counseling, Johns Hopkins University Member, Advisory Board, Encyclopedia of the Human Genome 1999 Nature/Scientific American Publishing Group Member, Advisory Board for CME program: Managing ADHD: 1999 Approaches to Diagnosis and Treatment Medical Education Systems Member, Editorial Advisory Board Clinical Psychology for the Next Century 1997 American Psychological Association Press Member, Clinical Psychopathology Review Committee, National Institute of Mental Health 1995-1999 Ad Hoc Member, Medical Research Review Committee US Department of Veterans Affairs 1995-Present Ad Hoc Member, Mental Health Special Project Review Committee, 1993-Present National Instiute of Mental Health Board Member, American Journal of Medical Genetics 1992 - Present Associate Editor, Neuropsychiatric Genetics 1992-1999 International Service Date(s) Member, Program Committee, 2007 World Congress of Psychiatric Genetics International Society of Psychiatric Genetics 2005 – 2007 Member, Advisory Board, Bergen Mental Health Research Center, Bergen Norway 2005-Present Member, Fund Raising Committee, International Society of Psychiatric Genetics 2004 – Present Member, Board of Directors International Society of Psychiatric Genetics 2003 – Present Member, Program Committee, 2006 World Congress of Psychiatric Genetics International Society of Psychiatric Genetics 2004 – 2006 Program Chair, 2005 World Congress of Psychiatric Genetics International Society of Psychiatric Genetics 2003 – 2005 Member, Program Committee, 2004 World Congress of Psychiatric Genetics International Society of Psychiatric Genetics 2003 – 2004 Ad Hoc Member, Application Review Committee 2001 – Present Australian National Health and Medical Board Board Member, Board of Advisors, Institute of Mental Health, Singapore 2000 – Present Ad Hoc Member, Science Foundation Ireland Review Committee 2000 – Present Science Foundation of Ireland Ad Hoc Member, Health Research Board Ireland Review Committee 2000 – Present Health Research Board of Ireland Ad Hoc Member, Wellcome Trust Review Committee, The UK Wellcome Trust 1997 – Present

PROFESSIONAL SOCIETIES:

1985-Present American Psychological Association Member 1988-Present American Psychological Society Charter Member 1989-Present American Association for the Advancement of Science Member 1990-Present Behavior Genetics Association Member 1991-Present New York Academy of Sciences Member 1992-Present International Genetic Epidemiology Society Member 1993-Present American Society of Human Genetics Member 1993-Present American Statistical Association Member 1996-Present International Society of Psychiatric Genetics Member 2003-Present International Society of Psychiatric Genetics Board Member MAJOR ADMINISTRATIVE RESPONSIBILITIES:

Year Title Institution 1983-1985 Project Coordinator Psychiatric Epidemiology Research Unit, Butler Hospital 1985-1991 Health Statistician Department of Psychiatry, Brockton/West Roxbury

Veterans Affairs Medical Center 1986-1991 Director of Family Studies Section of Psychiatric Epidemiology & Genetics,

Psychiatry Service, Brockton/West Roxbury VAMC 1989-Present Assistant to Chair Veterans Affairs Cooperative Schizophrenia Linkage

Program 1992-1999 Associate Editor Neuropsychiatric Genetics 1998-Present Academic Director NIMH Funded Psychiatric Genetics Training Program,

Harvard Institute of Psychiatric Epidemiology & Genetics 1998-Present Chair ADHD Molecular Genetics Network 1999-Present Co-Editor Neuropsychiatric Genetics

1999-Present Co-Director MGH Child & Adolescent Psychopharmacology Continuing Education Course

2001-Present Co-Director Johnson and Johnson Psychopathology Research Center at the Massachusetts General Hospital

2002-Present Chair Chair, International Multicenter ADHD Genetics Project 2002-Present Chair ADHD Translational Research Network 2003-Present Co-Director Center for the Study of ADHD and its Comorbidities at the

Massachusetts General Hospital 2003-Present Board Member International Society of Psychiatric Genetics 2003-Present Chair Program Committee for 2005 World Congress of

Psychiatric Genetics RESEARCH SUPPORT:

Past Funding

Years Funding Source Role Grant Title

1986 US Department of Veterans Affairs Principal Investigator

Drug Reduction Strategies in Schizophrenia (Small Grant)

1986-1988 US Department of Veterans Affairs Principal Investigator

Neuropsychological Functioning and Genetic Risk Prediction in

Past Funding


Schizophrenia 1987-1988 Massachusetts Commonwealth

Research Center Principal Investigator

Molecular Genetics of Schizophrenia (Small Grant)

1987-1991 National Institute of Mental Health Co-Principal Investigator

Genetic Factors and Drug Response in Schizophrenia (R01)

1988-1993 National Institute of Drug Abuse Investigator A Twin Study of Drug Abuse and Dependence (R01)

1988-1990 National Institute of Mental Health Investigator Subtyping Schizophrenia: An Epidemiological Approach (R01)


A Controlled Family Study of Attention Deficit Disorder (R01)


Schizophrenia: Psychopathology and Heterogeneity (R01)


Diagnostic Centers for Psychiatric Linkage Studies (U01)

1990-1993 US Department of Veterans Affairs Principal Investigator

Evaluation of Methods for Morbidity Risk Estimation: A Simulation Study (Merit Award)


Prospective High Risk Study of ADHD and Related Disorders (R01)

1992-1998 US Department of Veterans Affairs Investigator Genetic Linkage Study of Schizophrenia (Cooperative Study Award)


A Family-Genetic Study of Girls with Attention Deficit Hyperactivity Disorder (R01)


Children of Agoraphobic Patients (R01)


Diagnostic Centers for Psychiatric Linkage Studies (U01)

1998-2001 Theodore & Vada Stanley Foundation Investigator The Theodore and Vada Stanley Foundation Award for theStudy of Juvenile Mania (Foundation Grant)

2000-2001 Shire-Richwood Pharmaceuticals Principal Investigator

Meta-Analysis of Stimulant Treatment Data

1999-2002 National Institute of Mental Health Investigator A Longitudinal Follow-Up of Children at Risk for Anxiety Disorders (R01)

1998-2003 National Institute of Mental Health Principal Investigator

Collaborative ADHD Genetics Conference (R13)


Testing the Validity of Adult Attention Deficit Hyperactivity Disorder (R01)

1998-2003 National Institute of Child Health and Human Development

Co-Principal Investigator

Long-Term Outcome Of Attention Deficit Hyperactivity Disorder (R01)

Past Funding


1998-2003 National Institute of Mental Health Investigator A Longitudinal, Follow-Up Study of ADHD Girls and Their High Risk Siblings (R01)

1998-2003 National Cancer Institute Investigator Prevention of Cigarette Smoking in ADHD Youth (R01)

1998-2003 National Institute of Mental Health Investigator Schizophrenia: Psychopathology and Heterogeneity (R01)

1999-2003 National Institute of Mental Health Investigator Psychiatric Genetics Training Grant (T31)

1999-2004 National Institute of Drug Abuse Investigator Molecular Genetics of Heroin Dependence (R01)


Principal Investigator

Genetic Linkage Study of Attention Deficit Hyperactivity Disorder (R01)



An Ecogenetic Study of Attention Deficit Hyperactivity Disorder (R01)


Supplement to Collaborative ADHD Genetics Conference (R13)

2002-2003 Shire Pharmaceutical Development Principal Investigator

Phase IV Mixed Amphetamine Salts-XR Data Analyses

2002-2003 McNeil Consumer Pharmaceuticals Principal Investigator

Phase IV OROS Methylphenidate Data Analyses

2002-2003 Eli Lilly Principal Investigator

Phase IV Atomoxetine Data Analyses

2003 McNeil Consumer Pharmaceuticals Principal Investigator

Meta-Analyses of Adult ADHD Clinical Trials

Current Funding:


1998-2005 National Institute of Mental Health

Investigator A Genetic Linkage Study of Schizophrenia (R01)



International Multi-center ADHD Genetics Project (R01)



Searching for ADHD Susceptibility Genes (R01)



Integrating Clinical and Basic Processes in ADHD (R21)


Investigator Long-Term Outcome Of Attention Deficit Hyperactivity Disorder (R01)


Investigator Follow-up and Family Study of Pediatric Bipolar Disorder (R01)

2003-2004 McNeil Consumer Pharmaceuticals


Validating the Full Spectrum of ADHD Psychopathology

Current Funding:




Collaborative ADHD Genetics Conference (R13)


Investigator The Genetics of Endophenotypes and Schizophrenia


Investigator DAT Binding by Pet in Adult ADHD


Investigator A Longitudinal Follow-Up of Children at Risk for Anxiety Disorders (R01)

1999-2004

National Institute of Drug Abuse Subcontract PI

Molecular Genetics of Heroin Dependence (R01)


Subcontract PI

Translational Study of Bipolar Disorder (R01)

2005-2008 National Institute of Drug Abuse Principal Investigator

Phenotypes for Molecular Genetic Studies of ADHD and Substance Use Disorders (R01)

Grants Under Review for Funding:




Psychiatric Allelic Association Database


Investigator A Longitudinal, Follow-Up Study of ADHD Girls and Their High Risk Siblings (R01)


Investigator Temperamenal Antecedants of Bipolar Disorder in Children (R01) (7/04 submission)


Investigator Follow-up of Children with Obsessive Compulsive Disorder (R01) (7/04 submission)



Searching for ADHD Susceptibility Genes (R01) (7/04 submission)

TEACHING EXPERIENCE LOCAL TEACHING Years Course/Presentation Role Students Prep. Time 1985-1990 Brockton/ West Roxbury VAMC,

Psychology Internship Lecturer 5 to 10 psychology

interns and fellows 20 hours per year

1985-1990 Overview of Psychiatric Epidemiology and Genetics

Lecturer 10 to 15 nurses 20 hours per year

1985-1991 Methods in Psychiatric Genetics Lecturer 10 to 20 graduate students

60 hours per year

1987-Present

Tutorials in Epidemiologic and Statistical Methods (MGH Pediatric Psychopharmacology Research Program)

Course Director

20 to 30 junior faculty, residents, interns and research assistants

2 hours per week

1991-Present

Graduate Student Tutorials, Harvard School of Public Health

Preceptor 1 student each year Variable

LOCAL TEACHING Years Course/Presentation Role Students Prep. Time 1991 Methods in Behavioral Genetics Presenter Residents & Medical

Students 30 hours per year

1998-Present

NIMH Funded Psychiatric Genetics Training Program

Academic Director

4 fellows over 4 years 3 hours per week

1999-2003 NIMH Funded Psychiatric Genetics Training Program

Program Organizer

4 fellows over 4 years 2 hours per week

1999-Present

MGH Pediatric Psychopharmacology Course

Lecturer 5 to 15 nurses, residents and fellos

20 hour per year

CONTINUING EDUCATION

Year Course Role Prep. Time

Contact Time

1988-Present

Attention Deficit Hyperactivity Disorder Across the Lifespan (MGH CME Program)

Faculty 20 hours/yr 1 hour Lecture; 3 hour student consultations

1995 Comorbidity in ADHD: Artifact or Reality? (CME Program at Annual Meeting of the American Psychiatric Association)

Faculty 20 hours 1 hour lecture

1998 Attention Deficit Disorder and Bipolar Disorder: A Familial Subtype? (CME Program at Annual Meeting of the American Psychiatric Association)


1999 Attention Deficit Hyperactivity Disorder Educational Summit (Meeting to plan National ADHD CME Course)

Faculty 5 hours 8 hour discussion session

1999-2001

Managing ADHD: Approaches to Diagnosis and Treatment (Medical Education Systems CME Program)

Faculty 4 hours per year

4 one hour sessions

1999 What's Genetic about Child Psychiatry III: New Methods and Findings. American Academy of Child and Adolescent Psychiatry CME Program


2000 Genetics of Adult ADHD Continuing Medical Education (CME Program at Annual Meeting of the American Psychiatric Association)


2000 Genetics of Adult ADHD. (CME Program at Annual Meeting of the American Psychiatric Association)


2001 Psychiatric Comorbidity: It’s not just symptom overlap or bad ADHD. (CME Program at Annual Meeting of the American Psychiatric Association)


2001 ADHD in the USA: Is it A Valid Disorder (Colwood HealthWorld CME Program)

Developer & Faculty

120 hours Series of 1 hour lectures

2001 Examining New Advances in the Diagnosis and Management of ADHD (Medical Education Systems CME Program)


Series of 1 hour lectures

2001 Advancing the Cornerstone of ADHD Therapy (Strategic Implications International CME Program)


Series of 1 hour lectures

2001 The Genetics of ADHD (CME program at Annual Faculty 20 hours 1 hour lecture

CONTINUING EDUCATION Year Course Role Prep.

Time Contact Time

Meeting of American Academy of Pediatrics) 2002 The Genetics of Adult ADHD (CME program at

Annual Meeting of American Psychiatric Association)


2002 Introduction to Psychostimulant Treatment of ADHD: The Evolution of Optimal Treatment Strategies (CME program at Annual Meeting of American Psychological Association)


2002 Compliance with ADHD Therapy (CME program at Annual Meeting of American Psychological Association)


2002

ADHD: Where does it begin? An Overview of Disease Genetics (CME program at Annual Meeting of American Academy of Child and Adolescent Psychiatry)


2002 Genetic and other Biological/ Physiological markers for ADHD (CME program at Annual Meeting of American Academy of Pediatrics)


2003 Genetic of ADHD (CME program at Annual Meeting of American Academy of Child and Adolescent Psychiatry


2003 ADHD and Comorbid Conditions (PDI Education & Communications CME Program)

Faculty 40 hours Series of 1 hour lectures

2003 ADHD and Substance Abuse (PDI Education & Communications CME Program)


2004 Genetics of Adult ADHD (CME program at Annual Meeting of American Psychiatric Association)


2004 ADHD: A Case Based Approach (PDI Education & Communications CME Program)


2004-present

The Genetics of ADHD (MGH Psychiatric Genetics CME program)

Faculty 15 hours Half hour lecture

2004-present

The Genetics of Psychotic Disorders (MGH Psychiatric Genetics CME program)

Faculty 15 hours Half hour lecture

LEADERSHIP ROLES RELATED TO TEACHING Years Organization Description 1989-Present Massachusetts General

Hospital As Director of Pediatric Psychopharmacology Research, I am responsible for training post-doctoral students and junior investigators in all phases of psychiatric research: data collection, statistical analysis, manuscript writing, and grant writing

1998-present Harvard School of Public Health

Academic Director, NIMH Funded Psychiatric Genetics Training Program and Preceptor for Graduate Program in Psychiatric Epidemiology

1998-present NIMH Funded Attention Deficit Hyperactivity

As the principal investigator of an NIMH funded conference grant, I am responsible for organizing yearly meetings of investigators and

LEADERSHIP ROLES RELATED TO TEACHING Years Organization Description

Disorder Molecular Genetics Network

trainees studying the molecular genetics of Attention Deficit Hyperactivity Disorder

1999-present Massachusetts General Hospital

Co-director of the yearly MGH Child and Adolescent Psychopharmacology Continuing Education Course

TRAINEES Duration Name Current Position 1987-1989 John Pepple, PhD Instructor, Dept. of Psychiatry, Harvard Medical School 1987-1989 Keith Hawkins, PhD Associate Professor, Dept. of Psychiatry, Yale University School of

Medicine 1988-1995 William Kremen, PhD Associate Professor, Dept. of Psychiatry , UCSD 1988-1993 Wei Jen Chen, MD Professor of Psychiatry Institute of Public Health National Taiwan

University College of Medicine 1989-1993 Susan Santangelo, PhD Assistant Professor, Dept. of Psychiatry, Tufts University 1990-1995 Tim Wilens, MD Associate Professor, Dept. of Psychiatry, Harvard Medical School 1990-1995 Tom Spencer, MD Associate Professor, Dept of Psychiatry, Harvard Medical School 1991-1993 Sharon Milberger, PhD Research Associate, Dev. Disabilities Institute, Wayne State Univ. 1992-1998 Dina Hirshfeld, PhD Instructor, Dept. of Psychiatry Harvard Medical School 1992-1998 Eric Mick, ScD Instructor, Dept. of Psychiatry Harvard Medical School 1997-1999 Jordan Smoller, MD Instructor, Dept. of Psychiatry, Harvard Medical School 1995-1999 James Hudziak, MD Assistant Professor of Psychiatry and Medicine, Director, Medical

Student Education, Dept. of Psychiatry, University of Vermont 1997-1999 Alysa Doyle, PhD Instructor, Dept. of Psychiatry, Harvard Medical School 1999-2001 Kim Mullin Doctoral Student, Clinical Psychology University of Colorado 1999-2001 Sharon Cohan Doctoral Student, Clinical Psychology UC San Diego 1999-2001 Shao Zhu, MD Research Fellow, Massachusetts Mental Health Center 1999-2000 Daniel Geller, MD Instructor, Dept. of Psychiatry, Harvard Medical School 1999-2000 Bill Stone, PhD Instructor; Dept. of Psychiatry, Harvard Medical School 1999-2003 Michael Monuteaux, ScD Instructor; Dept. of Psychiatry, Harvard Medical School 2000-2002 Levi Taylor, PhD Lecturer, Eastern Washington University 2000-2002 Marsha Wilcox, ScD Assistant Professor, Epidemiology and Biostatistics, Boston Univ. 2000-2003 Heather Volk, MA Doctoral Student, Dept. of Epidemiology, St. Louis University School

of Public Health 2000-2003 Kate Murray Doctoral Student, Clinical Psychology Arizona State 2001-2003 Steven Glatt, PhD Assistant Professor, University of California, San Diego 2001-2003 Jen Buchwald Doctoral Student, Clinical Psychology Yeshiva University 2001-2003 Hannah Schofield Doctoral Student, Clinical Psychology Penn State 2001-2003 Joanne Peart Doctoral Student, Clinical Psychology Emory University 2001-2003 Hamid Mostafavi, MD Post-Doctoral Fellow, Harvard Medical School 2000-present Sakae Takahashi, MD Post-Doctoral Fellow, Psychiatric Genetics Training Program, Harvard

School of Public Health 2002-present Jessica Su Doctoral Student, Harvard School of Public Health 2002-present Eve Valera, PhD Instructor, Dept. of Psychiatry, Harvard Medical School 2002-present Heidi Wencel, PhD Post-Doctoral Fellow, Psychiatric Genetics Training Program, Harvard

School of Public Health 2002-present Franziska Gamma, M.D Post-Doctoral Fellow, Psychiatric Genetics Training Program, Harvard

School of Public Health 2002-present Yu-Chi Yeh, MD Post-Doctoral Fellow, Psychiatric Genetics Training Program, Harvard

School of Public Health 2003-present Christopher Chabris, PhD Research Associate, Department of Psychology, Harvard College 2003-present Jang Woo Kim, PhD Post-Doctoral Fellow, Psychiatric and Neurodevelopmental Genetics

TRAINEES Duration Name Current Position

Unit, Massachusetts General Hospital and Harvard Medical School 2004-present Christine Finn, MD Post-Doctoral Fellow, Psychiatric Genetics Training Program, Harvard

School of Public Health BIBLIOGRAPHY

Original Articles Note: I was listed as the eighth highest producer of High Impact Papers in Psychiatry between 1990 and 1999 as determined by the Institute for Scientific Information (Science, 2000, Vol 288, pg 959).

1. Levin IP, Faraone, SV, Herring RD. Measuring personal satisfaction under varying economic conditions. Bulletin of the Psychonomic Society 1980;16:356-358.

2. Levin IP, Faraone SV, McGraw J. Functional measurement in economic psychology. Journal of Economic Psychology 1981;4:303-318.

3. Faraone SV. The behavior as language analogy: A critical evaluation and an application to the behavior of conversational interaction. Behaviorism 1983;11:27-43.

4. Levin IP, Johnson RD, Faraone SV. Information integration in price-quality tradeoffs: The effect of missing information. Memory and Cognition 1984;12:96-102.

5. Faraone SV, Hurtig RR. An examination of social skill, verbal productivity and Gottman's model of interaction using observational methods and sequential analyses. Behavioral Assessment 1985;7:349-366.

6. Tsuang MT, Bucher KD, Fleming JA, and Faraone SV. Transmission of affective disorders: An application of segregation analysis to blind family study data. Journal of Psychiatric Research 1985;19:23-29.

7. Tsuang MT, Faraone SV, Fleming JA. Familial transmission of major affective disorders: Is there evidence supporting the distinction between unipolar and bipolar disorders? British Journal of Psychiatry 1985;146:268-271.

8. Stout RL, Stevenson J, Faraone SV, Simpson J. Systems for multivariate monitoring of behavioral status over time. Behavior Research Methods, Instrumentation and Computers 1986;18:141-146.

9. Faraone SV. A Statistical Analysis System (SAS) computer program for Markov chain analysis. Journal of Psychopathology and Behavioral Assessment 1986;8:367-379.

10. Faraone SV, Curran JC, Laughren T, Faltus F, Johnston R, Brown WA. Neuroleptic bioavailability, Psychosocial factors and clinical status: A one year study of schizophrenic outpatients after dose reduction. Psychiatry Research 1987;19:311-322.

11. Faraone SV, Dorfman DD. Lag sequential analysis: Robust statistical methods. Psychological Bulletin 1987;101:312-323.

12. Faraone SV, Brown WA, Laughren T. Serum neuroleptic levels, prolactin and relapse: A two year study of schizophrenic outpatients. Journal of Clinical Psychiatry 1987;48:151-154.

13. Faraone SV, Lyons M.J, Tsuang MT. Sex differences in affective disorder: Genetic transmission. Genetic Epidemiology 1987;4:331-343.

14. Faraone SV, Tsuang MT, Gutierrez J. Long term outcome and family psychiatric illness in unipolar and bipolar disorders. Psychopharmacology Bulletin 1987;23:465-467.

15. Faraone SV, Tsuang MT. Familial links between schizophrenia and other disorders: Application of the multifactorial polygenic model. Psychiatry: Interpersonal and Biological Processes 1988;51:37-47.

16. Faraone SV, Dorfman DD. Testing the significance of interobserver agreement measures in the presence of autocorrelation: The Jackknife procedure. Journal of Psychopathology and Behavioral Assessment 1988;10:39-47.

17. Goldfeld AE, Mollica RF, Pesavento BH, Faraone SV. The physical and psychological sequelae of torture. Journal of the American Medical Association 1988; 259:2725-2729.

18. Faraone SV, Cirelli V, Curran JP, Brown WA. Neuroleptic dose reduction for schizophrenic outpatients: A three year follow-up. Hospital and Community Psychiatry, 1988;39:1207-1208.

19. DeLuca A, Pittman D, Gutierrez JM, Faraone SV. Psychosocial changes in persistently psychotic schizophrenic patients after an 80% reduction of neuroleptic medication. Journal of Psychosocial Nursing 1988;26:13-17.

20. Faraone SV, Young AS, Brown WA. Neuroleptic non-response and affective symptoms: A two year prospective study of schizophrenic outpatients. Psychiatry Research 1989;28:315-321.

21. Faraone SV, Green AI, Brown WA, Yin P, Tsuang M.T. Neuroleptic dose reduction in persistently psychotic patients. Hospital and Community Psychiatry 1989;40:1193-1195.

22. Goldstein JM, Tsuang, MT, Faraone SV. Gender and schizophrenia: Implications for understanding the heterogeneity of the illness. Psychiatry Research 1989;28:243-253.

23. Young AS, Faraone SV, Brown WA. Correction of serum neuroleptic activity for blood to brain distribution: A method that may render radioreceptor assay results comparable between neuroleptics. Journal of Clinical Psychopharmacology 1989;9:361-364.

24. Biederman J, Rosenbaum JF, Hirshfeld DR, Faraone SV, Bolduc EA, Gersten M, Meminger SR, Snidman N, Reznick JS, Kagan J. Psychiatric correlates of behavioral inhibition in young children of parents with and without psychiatric disorders. Archives of General Psychiatry 1989;47:21-26.

25. Lyons MJ, Faraone SV, Kremen WS, Tsuang MT. Familial and sporadic schizophrenia: A simulation study of statistical power. Schizophrenia Research 1989; 2: 345-353.

26. Lyons MJ, Kremen WS, Tsuang MT, Faraone SV. Investigating putative genetic and environmental forms of schizophrenia: Methods and findings. International Review of Psychiatry 1989;1:259-276.

27. Tsuang MT, Lyons MJ, Faraone SV. Heterogeneity of schizophrenia: Conceptual models and analytic strategies. British Journal of Psychiatry 1990;156:17-26.

28. Gracia RI, Gutierrez JM, Faraone SV, Tsuang MT. Treatment with lorazepam for increased anxiety after reduction to low dose neuroleptic therapy in a chronic schizophrenic patient. Hospital and Community Psychiatry 1990;41:197-198.

29. Biederman J, Faraone SV, Knee D, Munir K. Retrospective assessment of attention deficit disorder in non-referred individuals. Journal of Clinical Psychiatry 1990;51:102-106.

30. Hawkins KA, Faraone SV, Pepple JR, Seidman LJ, Tsuang MT. WAIS-R validation of the Wonderlic Personnel Test as a brief intelligence measure in a psychiatric sample. Psychological Assessment: A Journal of Consulting and Clinical Psychology 1990;2:198-201.

31. Faraone SV, Kremen WS, Tsuang MT. Genetic transmission of major affective disorders: Quantitative models and linkage analyses. Psychological Bulletin 1990;108: 109-127.

32. Biederman J Faraone SV, Keenan K, Tsuang MT. Family genetic and psychosocial risk factors in attention deficit disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 1990, 29, 526-533.

33. Goldstein J, Faraone, SV, Chen W, Tolomiczencko G, Tsuang MT. Sex differences in the familial transmission of schizophrenia. British Journal of Psychiatry 1990;156:819-826.

34. Green AI, Faraone SV, Brown WA. Prolactin shifts after neuroleptic withdrawal Psychiatry Research 1990;32:213-219.

35. Biederman J, Keenan K, Faraone SV. Attention Deficit Disorder: Family genetic risk factors and comorbidity. Pediatric and Adolescent Medicine 1991;1:70-94.

36. Biederman J, Keenan K, Faraone, SV. Parent-based diagnosis of attention deficit disorder predicts a diagnosis based on teacher report. Journal of the American Academy of Child and Adolescent Psychiatry 1990;29:698-701.

37. Faraone SV, Biederman J, Keenan K, Tsuang MT. A family-genetic study of girls with DSM-III attention deficit disorder. American Journal of Psychiatry 1991;148:112-117.

38. Faraone SV, Biederman J, Keenan K, Tsuang MT. Separation of DSM-III Attention Deficit Disorder and Conduct Disorder: Evidence from a Family-Genetic Study of American Child Psychiatric Patients. Psychological Medicine 1991;21:109-121.

39. Biederman J, Faraone SV, Keenan K, Tsuang MT. Attention Deficit Disorder and major depression: Evidence supporting a family-genetic relationship. Archives of General Psychiatry 1991;48:633-642.

40. Biederman J, Faraone SV, Keenan K, Steingard R, Tsuang MT. Familial association between attention deficit disorder (ADD) and anxiety disorder. American Journal of Psychiatry 1991;148:251-256

41. Rosenbaum JF, Biederman J, Hirshfeld DR, Bolduc EA, Faraone SV, Kagan J, SR Snidman N, and Reznick JS. Further evidence of an association between behavioral inhibition and anxiety disorders: Results from a family study of children from a non-clinical sample. Journal of Psychiatric Research 1991;25:49-65.

42. Tsuang MT, Gilbertson MW, Faraone SV. The genetics of schizophrenia: Current knowledge and future directions. Schizophrenia Research 1991;4:157-171.

43. Biederman, J, Rosenbaum JF, Bolduc EA, Faraone SV, Hirshfeld DR. A high risk study of young children of parents with panic disorder and agoraphobia with and without comorbid major depression. Psychiatry Research 1991;37:333-348.

44. Seidman LJ, Pepple JR, Faraone SV, Kremen WS, Cassens G, McCarley RW, Tsuang MT. Wisconsin Card Sorting Test performance over time in schizophrenia: Preliminary evidence from clinical follow-up and neuroleptic reduction studies. Schizophrenia Research 1991;5:233-242.

45. Kremen WS, Seidman LJ, Faraone SV, Pepple JR, Tsuang MT. Attention/information processing factors in psychotic disorders: Replication and extension of recent neuropsychological findings. Journal of Nervous and Mental Disease 1992;180:88-92.

46. Kremen WS, Tsuang MT, Faraone SV, Lyons MJ. Using vulnerability indicators to compare conceptual models of genetic heterogeneity in schizophrenia. Journal of Nervous and Mental Disease 1992;180:141-152.

47. Seidman LJ, Talbot NL, Kalinowski AG, McCarley RW, Faraone SV, Kremen WS, Pepple JR, Tsuang MT. Neuropsychological probes of frontal-limbic system dysfunction in schizophrenia: Olfactory identification and Wisconsin card sorting performance. Schizophrenia Research 1992;6:55-66.

48. Hirshfeld DR, Rosenbaum JF, Biederman J, Bolduc EA, Faraone SV, Snidman N, Reznick JS, and Kagan J, SR. Stable behavioral inhibition and its association with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry 1992;31:103-111.

49. Biederman J, Faraone SV, Keenan K, Benjamin, J, Krifcher B., Moore C, Sprich S, Ugaglia K, Jellinek M, Steingard R, Spencer T, Norman D, Kolodny R, Kraus I., Perrin J, Keller MB, Tsuang MT. Further Evidence for Family-Genetic Risk Factors in Attention Deficit Hyperactivity Disorder (ADHD): Patterns of Comorbidity in Probands and Relatives in Psychiatrically and Pediatrically Referred Samples. Archives of General Psychiatry 1992;49:728-738.

50. Faraone SV, Simpson JC, Brown W. Mathematical models of complex dose-response relationships: Implications for experimental design in psychopharmacologic research, Statistics in Medicine 1992;11:685-702.

51. Semrud-Clikeman M, Biederman J, Sprich S, Krifcher B, Faraone SV, Norman D. Comorbidity between attention deficit disorder with hyperactivity and learning disability: A review and report in a clinically referred sample. Journal of the American Academy of Child and Adolescent Psychiatry 1992;31:439-448.

52. Chen WJ, Faraone SV, Tsuang MT. Linkage studies of schizophrenia: A simulation study of statistical power. Genetic Epidemiology 1992;9:123-139.

53. Rosenbaum JF, Biederman J, Hirshfeld DR, Bolduc EA, Faraone SV, Kagan JSR. Comorbidity of parental anxiety disorders as risk for childhood onset anxiety in inhibited children. American Journal of Psychiatry 1992;149:475-481.

54. Goldstein JM, Faraone SV, Chen WJ, Tsuang MT. Gender and the familial risk for schizophrenia: Disentangling confounding factors. Schizophrenia Research 1992;7:135-140.

55. Chen WJ, Faraone SV, Tsuang MT. Estimating age at onset distribution: A review of methods and issues. Psychiatric Genetics 1992;2:219-238.

56. Faraone SV, Biederman J, Chen WJ, Krifcher B, Keenan K, Moore C, Sprich S, Tsuang MT. Segregation analysis of attention deficit hyperactivity disorder, Psychiatric Genetics, 1992;2:257-275.

57. Biederman J, Baldessarini RJ, Wright V, Keenan K, Faraone SV. A double blind placebo controlled study of desipramine in the treatment of attention deficit disorder: III: Lack of impact of comorbidity and family history factors on clinical response. Journal of the American Academy of Child and Adolescent Psychiatry 1993;32:199-204.

58. Biederman J, Faraone SV, Milberger S, Doyle A. Diagnoses of attention deficit hyperactivity disorder from parent reports predict diagnoses based on teacher reports. Journal of the American Academy of Child and Adolescent Psychiatry 1993;32:315-317.

59. Faraone SV, Biederman J, Sprich S, Chen WJ, Tsuang, MT. Efficiency of Diagnostic Criteria for Attention Deficit Disorder: Toward an Empirical Approach to Designing and Validating Diagnostic Algorithms. Journal of the American Academy of Child and Adolescent Psychiatry 1993;32:166-174.

60. Chen WJ, Faraone SV, Orav EJ, Tsuang MT. Estimating age at onset distributions: The bias from prevalent cases and its impact on risk estimation. Genetic Epidemiology 1993; 10:43-60.

61. Rosenbaum JF, Biederman J, Bolduc-Murphy EA, Faraone SV, Chaloff J, Hirshfeld DR, Kagan JSR. Behavioral inhibition in childhood: A risk factor for anxiety disorders. Harvard Review of Psychiatry 1993;1:2-16.

62. Biederman J. Rosenbaum JF, Bolduc-Murphy EA, Faraone SV, Chaloff J, Hirshfeld DR, Kagan JSR. A three year follow-up of children with and without behavioral inhibition. Journal of the American Academy of Child and Adolescent Psychiatry 1993;32:814-821.

63. Faraone SV, Biederman J, Krifcher-Lehman B, Keenan K, Moore C, Sprich-Buckminster S, Ugaglia K, Jellinek M, Spencer T, Norman D, Seidman LJ, Kolodny R, Benjamin J, Kraus I, Perrin J, Chen WJ, Tsuang MT. Evidence for independent transmission in families for attention deficit hyperactivity disorder (ADHD) and learning disabilities: Results from a family-genetic study of ADHD. American Journal of Psychiatry 1993;150:891-895.

64. Yeung AS, Lyons MJ, Waternaux CM, Faraone SV, Tsuang MT. The relationship between DSM-III personality disorders and the five-factor model of personality. Comprehensive Psychiatry 1993;34:227-234.

65. Seidman LJ, Pepple JR, Faraone SV, Kremen WS, Green AI, Brown WA, Tsuang MT. Neuropsychological performance in chronic schizophrenia in response to neuroleptic dose reduction. Biological Psychiatry 1993;33:575-584.

66. Sprich-Buckminster S, Biederman J, Milberger S, Faraone SV, Krifcher-Lehman B. Are perinatal complications relevant for the manifestation of ADD?: Issues of comorbidity and familiality. Journal of the American Academy of Child and Adolescent Psychiatry 1993;32:1032-1037.

67. Biederman J, Faraone SV, Chen WJ. The Social Adjustment Scale for Children and Adolescents: Concurrent Validity in ADHD Children. Journal of the American Academy of Child and Adolescent Psychiatry 1993;32:1059-1064.

68. Faraone SV, Biederman J, Krifcher-Lehman B, Spencer T, Norman D, Seidman LJ, Kraus I, Perrin J, Chen WJ, Tsuang MT. Intellectual Performance and School Failure in Children with Attention Deficit Hyperactivity Disorder and in their Siblings. Journal of Abnormal Psychology 1993;102:616-623.

69. Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA, Mick E, Krifcher-Lehman B, Doyle A. Patterns of Psychiatric comorbidity, Cognition and Psychosocial Functioning in Adults with Attention Deficit Hyperactivity Disorder. American Journal of Psychiatry 1993;150:1792-1798.

70. Blacker D, Lavori PW, Faraone SV, Tsuang MT. Unipolar Relatives in Bipolar Pedigrees: A Search for Indicators of Underlying Bipolarity. American Journal of Medical Genetics, Neuropsychiatric Genetics 1993;48:192-199.

71. Yeung AS, Lyons MJ, Waternaux CM, Faraone SV, Tsuang MT. A family study of self reported personality traits and DSM-III-R personality disorders. Psychiatry Research 1993;48:243-255.

72. Yeung AS, Lyons MJ, Waternaux CM, Faraone SV, Tsuang MT. An empirical determination of thresholds for case identification: Validation of the Personality Diagnostic Questionairre-Revised. Comprehensive Psychiatry 1993;34:384-391.

73. Goldstein JM, Faraone SV, Chen WJ, Tsuang MT. The role of gender in understanding the familial transmission of schizoaffective disorder. British Journal of Psychiatry 1993; 163:763-768.

74. Tsuang MT, Faraone SV, Lyons MJ. Identification of the Phenotype in Psychiatric Genetics. European Archives of Psychiatry and Clinical Neuroscience 1993;682:1-12.

75. Biederman J, Faraone SV, Doyle A, Krifcher-Lehman B, Kraus I, Perrin J, Tsuang MT. Convergence of the Child Behavior Checklist with structured interview based psychiatric diagnoses of ADHD children with and without comorbidity. Journal of Child Psychology and Psychiatry 1993;34:1241-1251.

76. Seidman LJ, Yurgelun-Todd, D, Kremen WS, Woods BT, Goldstein JM, Faraone SV, Tsuang MT. Prefrontal and temporal-limbic measures and neuropsychological performance in chronic schizophrenia. Biological Psychiatry 1994;35:235-246.

77. Faraone SV, Tsuang MT. Measuring diagnostic accuracy in the absence of a gold Standard. American Journal of Psychiatry 1994;151:650-657.

78. Faraone SV, Biederman J, Milberger S. An exploratory study of ADHD among second degree relatives of ADHD children. Biological Psychiatry 1994;35:398-402.

79. Faraone SV, Chen WJ, Goldstein JM, Tsuang MT. Gender differences in the age at onset of schizophrenia. British Journal of Psychiatry 1994;164:625-629.

80. Kremen WS, Seidman LJ, Goldstein JM, Faraone SV, Tsuang, MT. Systematized delusions and neuropsychological function in paranoid and nonparanoid schizophrenia. Schizophrenia Research 1994;12:223-236.

81. Lyons MJ, Toomey R, Faraone SV, Tsuang MT. A comparison of schizotypal relatives of schizophrenic versus affective probands. American Journal of Medical Genetics, Neuropsychiatric Genetics 1994;54:279-285.

82. Chen WJ, Faraone SV, Biederman J, Tsuang MT. Diagnostic accuracy of the Child Behavior Checklist scales for attention deficit hyperactivity disorder: A receiver operating characteristic analysis. Journal of Consulting and Clinical Psychology 1994; 62:1017-1025.

83. Santangelo SL, Pauls DL, Goldstein JM, Faraone SV, Tsuang MT, Leckman JF. Tourette syndrome: What are the influences of gender and comorbid OCD? Journal of the American Academy of Child and Adolescent Psychiatry 1994;33:795-804.

84. Biederman J, Lapey KA, Milberger S, Faraone SV, Reed ED, Seidman LJ. Motor Preference, Major Depression and Psychosocial Dysfunction Among Children with Attention Deficit Hyperactivity Disorder. Journal of Psychiatric Research 1994;28:171-184.

85. Biederman J, Faraone SV, Spencer T, Wilens T, Mick E, Lapey KA. Gender Differences in a Sample of Adults with Attention Deficit Hyperactivity Disorder. Psychiatry Research 1994;53:13-29.

86. Biederman J, Milberger S, Faraone SV, Guite J, Warburton R. Associations Between Childhood Asthma and ADHD: Issues of Psychiatric Comorbidity and Familiality. Journal of the American Academy of Child and Adolescent Psychiatry 1994;33:842-848.

87. Nurnberger JI, Blehar MC, KaufmannCA, York-Cooler CY, Simpson S, Harkevey-Friedman J H, Severe J B, Malaspina D, Reich T, Miller M., Bowman ES, DePaulo JR, Cloninger CR, Robinson G, Moldin S, Gershon ES, Maxwell E, Guroff JJ, Kirch D, Wynne D, Berg K, Tsuang MT, Faraone SV, Pepple JR, Ritz AL. Diagnostic interview for genetic studies: Rationale, development, training, and reliability. Archives of General Psychiatry 1994;51:849-859.

88. Faraone SV, Chen WJ, Tsuang M.T. Estimating the morbidity risk for diseases having a variable age at onset. Psychiatric Genetics 1994;4:135-142.

89. Goldstein JM, Faraone SV, Chen WJ, Tsuang MT. Genetic heterogeneity may in part explain gender differences in the familial risk for schizophrenia. Biological Psychiatry 1995;38:808-813.

90. Biederman J, Milberger S, Faraone, SV, Seidman LJ, Lapey KA, Reed ED. Associations Between Childhood Asthma and ADHD: Is ADHD relevant in testing Geschwind's hypothesis of associations between reading disability, immune disorders and motor preference. Journal of Abnormal Child Psychology 1995;23:545-552.

91. Faraone SV, Biederman J, Chen WJ, Milberger S, Warburton R., Tsuang MT. Genetic Heterogeneity in Attention Deficit Hyperactivity Disorder: Gender, Psychiatric Comorbidity and Maternal ADHD. Journal of Abnormal Psychology 1995;104:334-335.

92. Biederman J, Faraone SV, Mick E, Spencer T, Wilens T, Kiely K, Guite J, Ablon JS, Reed E, Warburton R. High Risk for ADHD in Children of Parents with Childhood Onset ADHD: A Pilot Study. American Journal of Psychiatry 1995;152:431-435.

93. Lyons MJ, Toomey R, Faraone SV, Kremen WS, Yeung AS, Tsuang MT. Correlates of psychosis proneness in relatives of schizophrenics. Journal of Abnormal Psychology 1995;104:390-394.

94. Faraone SV, Seidman LJ, Kremen WS, Pepple JR, Lyons MJ, Tsuang MT. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: A diagnostic efficiency analysis. Journal of Abnormal Psychology 1995;104: 286-304.

95. Kremen WS, Seidman LJ, Faraone SV, Pepple JR, Lyons MJ, Tsuang MT. The "3 Rs" and neuropsychological function in schizophrenia: A test of the matching fallacy in biological relatives. Psychiatry Research 1995;56:135-143.

96. Biederman J, Wozniak J, Kiely K, Ablon S, Faraone SV, Mick E, Mundy E, Kraus I. CBCL clinical scales discriminate prepubertal children with structured-interview derived diagnosis of mania from those with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 1995;34:464-471.

97. Lyons M.J, Toomey R, Seidman LJ, Kremen WS, Faraone SV, Tsuang MT. Verbal learning and memory in relatives of schizophrenics: Preliminary findings. Biological Psychiatry 1995;37:750-753.

98. Faraone SV, Biederman JB, Milberger S. How reliable are maternal reports of their children's psychopathology?: One year recall of psychiatric diagnoses of ADHD children. Journal of the American Academy of Child and Adolescent Psychiatry 1995;34:1001-1008.

99. Biederman JB, Faraone SV, Mick E, Lelon E. Psychiatric comorbidity among referred juveniles with major depression: Fact or artifact? Journal of the American Academy of Child and Adolescent Psychiatry 1995;34:579-590.

100. Spencer T, Biederman J, Harding M, Wilens T, Faraone SV. The relationship between tic disorders and Tourette's Syndrome revisited. Journal of the American Academy of Child and Adolescent Psychiatry 1995;34:1133-1139.

101. Spencer, T, Wilens T, Biederman J, Faraone SV, Ablon S, Lapey K. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood onset attention deficit hyperactivity disorder. Archives of General Psychiatry 1995;52:434-443.

102. Wozniak J, Biederman J, Kiely K, Ablon JS, Faraone SV, Mundy E, Mennin D. Mania-like symptoms suggestive of childhood onset bipolar disorder in clinically referred children. Journal of the American Academy of Child and Adolescent Psychiatry 1995;34: 867-876.

103. Seidman LJ, Biederman J, Faraone SV, Milberger S, Norman D, Seiverd K, Benedict K, Guite J, Mick E, Kiely K. Effects of family history and comorbidity on the neuropsychological performance of ADHD children: Preliminary findings. Journal of the American Academy of Child and Adolescent Psychiatry 1995;34:1015-1024.

104. Biederman J, Milberger S, Faraone SV, Kiely K, Guite J, Mick E, Ablon S, Warburton R, Reed E. Family environmental risk factors for attention deficit hyperactivity disorder: A test of Rutter's indicators of adversity. Archives of General Psychiatry 1995;52:464-470.

105. Faraone SV, Kremen WS, Lyons MJ, Pepple JR, Seidman LJ, Tsuang MT. Diagnostic accuracy and linkage analysis: How useful are schizophrenia spectrum phenotypes? American Journal of Psychiatry 1995;152:1286-1290.

106. Biederman J, Milberger S, Faraone SV, Kiely K, Guite J, Mick E, Ablon JS, Warburton R, Reed E, Davis SG. Impact of adversity on functioning and comorbidity in children with attention deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 1995;34:1495-1503.

107. Milberger S, Biederman J, Faraone SV, Murphy J, Tsuang MT. Attention deficit hyperactivity disorder and comorbid disorders: Issues of overlapping symptoms. American Journal of Psychiatry 1995;152:1793-1799.

108. Lyons MJ, True WR, Eisen SA, Goldberg J, Meyer JM, Faraone SV, Eaves LJ, Tsuang MT. Differential Heritability of Adult and Juvenile Antisocial Traits. Archives of General Psychiatry 1995;53:906-915.

109. Biederman J, Santangelo SL, Faraone SV, Kiely K, Guite J, Mick E, Reed ED, Kraus I, Jellinek M., Perrin J. Clinical correlates of enuresis in ADHD and non-ADHD children. Journal of Child Psychology and Psychiatry 1995;36:865-877.

110. Tsuang MT, Faraone SV. The case for heterogeneity in the etiology of schizophrenia. Schizophrenia Research 1995;17:161-175.

111. Wozniak J, Biederman J, Mundy E, Mennin D, Faraone SV. A pilot family study of childhood-onset mania. Journal of the American Academy of Child and Adolescent Psychiatry 1995;34:1577-1583.

112. Seidman L, Benedict K, Biederman J, Bernstein J, Seiverd K, Milberger S, Norman D, Mick E, Faraone S. Performance of children with ADHD on the Rey-Osterrieth complex figure: A pilot neuropsychological study. Journal of Child Psychology and Psychiatry 1995;36:1459-1473.

113. Biederman J, Wilens T, Mick E, Milberger S, Faraone S, Spencer T. Psychoactive substance use disorder in adults with attention deficit hyperactivity disorder. American Journal of Psychiatry 1995;152:1652-1658.

114. Cohen LS, Sichel DA, Faraone SV, Robertson LM, Dimmock JA, Rosenbaum JF. Course of panic disorder during pregnancy and the puerperium: A preliminary study. Biological Psychiatry 1996;39:950-954.

115. Kremen WS, Seidman LJ, Faraone SV, Pepple JR, Lyons MJ, Tsuang MT. The '3 Rs' and neuropsychological function in schizophrenia: An empirical test of the matching fallacy. Neuropsychology 1996;10:1-10.

116. Santangelo SL, Pauls DL, Lavori PW, Goldstein JM, Faraone SV, Tsuang MT. Assessing risk for the Tourette spectrum of disorders among first degree relatives of probands with Tourette syndrome. American Journal of Medical Genetics, Neuropsychiatric Genetics 1996;67:107-116.

117. Faraone SV, Blehar M, Pepple J, Moldin S, Norton J, Tsuang MT, Nurnberger JI, Malaspina D, Kaufmann CA, Reich T, Cloninger CR, DePaulo JR, Berg K, Gershon ES, Kirch DG, Tsuang MT. Diagnostic Accuracy and Confusability Analyses: An Application to the Diagnostic Interview for Genetic Studies. Psychological Medicine, 1996;26:401-410.

118. Greene RW, Biederman JB, Faraone SV, Ouellette CA, Penn C, Griffin SM. Toward a new psychometric definition of social disability in children with attention deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 1996;35:571-578.

119. Seidman LJ, Oscar-Berman M, Kalinowski AG, Ajilor O, Kremen WS, Faraone SV, Tsuang MT. Experimental and clinical neuropsychological measures of prefrontal dysfunction in schizophrenia. Neuropsychology 1995;9:1-10.

120. Biederman J, Faraone S, Milberger S, Curtis S, Chen L, Marrs A, Ouelette C, Moore P, Spencer T. Predictors of persistence and remission of ADHD: Results for a three year prospective follow-up study of ADHD children. Journal of the American Academy of Child and Adolescent Psychiatry 1996;35:343-351.

121. Faraone SV, Biederman JB, Mick E, Wozniak J, Kiely K, Guite J, Ablon JS, Warburton R, Reed E. Attention deficit hyperactivity disorder in a multigenerational pedigree. Biological Psychiatry 1996;39:906-908.

122. Biederman J, Faraone SV, Mick E, Moore P, Lelon E. Child Behavior Checklist (CBCL) findings support the comorbidity between ADHD and major depression in a referred sample. Journal of the American Academy of Child and Adolescent Psychiatry 1996;35: 734-742.

123. Biederman J, Faraone SV, Milberger S, Guite J, Mick E, Chen L, Mennin D, Marrs A, Ouellette C, Moore P, Spencer T, Norman D, Wilens T., Kraus I, Perrin J. A prospective four year follow-up study of attention deficit hyperactivity and related disorders. Archives of General Psychiatry 1996;53:437-446.

124. Biederman J, Faraone SV, Mick E, Wozniak J, Chen L, Ouellette C, Marrs A, Moore P, Garcia J, Mennin D, Lelon E. Attention deficit hyperactivity disorder and juvenile mania: An overlooked comorbidity? Journal of the American Academy of Child and Adolescent Psychiatry 1996;35:997-1008.

125. Milberger S, Faraone SV, Biederman J, Testa M., Tsuang MT. A new phenotype definition of ADHD in relatives for genetic analyses. American Journal of Medical Genetics, Neuropsychiatric Genetics 1996;67:369-377.

126. Wilens TE, Biederman J, Prince J, Spencer TJ, Faraone SV, Warburton R, Schleifer D, Harding M, Linehan C, Geller D. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. American Journal of Psychiatry 1996;153:1147-1153.

127. Biederman J, Faraone SV, Milberger S, Garcia-Jetton J, Chen L, Mick E, Greene R, Wozniak J, Russell R. Is childhood oppositional defiant disorder a precursor to adolescent conduct disorder?: Findings from a four-year follow-up study of ADHD children. Journal of the American Academy of Child and Adolescent Psychiatry 1996;35: 1193-1204.

128. Faraone SV, Seidman LJ, Kremen WS, Toomey R, Lyons MJ, Tsuang MT. Neuropsychological functioning among the elderly nonpsychotic relatives of schizophrenic patients. Schizophrenia Research 1996;21:27-31.

129. Spencer T., Biederman J., Harding M., O'Donnell D, Faraone SV, Wilens T. Growth deficits in ADHD revisited: Evidence for disorder-associated growth delays. Journal of the American Academy of Child and Adolescent Psychiatry 1996;35:1460-1469.

130. Blehar MC, Faraone SV, Zeller P, Nurnberger JI, Tsuang MT, Kirch D, Reich T, Cloninger CR, Gershon ES, DePaulo JR, Gershefski J, Leela Rau N, Weise R, Shore D. Differentiation of schizoaffective bipolar disorder from schizophrenia and bipolar disorder. Depression 1996;3:309-315.

131. Blacker D, Faraone SV, Rosen AE, Guroff JJ, Adams P, Weissman MM, Gershon ES. Unipolar relatives in bipolar pedigrees: A search for elusive indicators underlying bipolarity. American Journal of Medical Genetics, Neuropsychiatric Genetics 1996;67: 445-454.

132. Faraone SV, Biederman J, Mennin D, Gershon J, Tsuang MT. A prospective four year follow-up study of children at risk for attention deficit hyperactivity disorder: Psychiatric, neuropsychological and psychosocial outcome. Journal of the American Academy of Child and Adolescent Psychiatry 1996;35:1449-1459.

133. Tsuang MT, Lyons MJ, Eisen SA, Goldberg J, True W, Lin N, Meyer JM, Toomey R, Faraone SV, Eaves L. Genetic influences on DSM-III-R drug abuse and dependence: A study of 3,372 twin pairs. American Journal of Medical Genetics, Neuropsychiatric Genetics 1996;67:473-477.

134. Mick E, Biederman J, Faraone SV. Is season of birth a risk factor for attention deficit hyperactivity disorder? Journal of the American Academy of Child and Adolescent Psychiatry 1996;35:1470-1476.

135. Milberger S, Biederman J, Faraone SV, Chen L, Jones J. Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children? American Journal of Psychiatry 1996;153:1138-1142.

136. Milberger S, Biederman J, Faraone SV, Guite J, Tsuang MT. Pregnancy delivery and infancy complications and ADHD: Issues of gene-environment interactions. Biological Psychiatry 1997;41:65-75.

137. Biederman J, Wilens TE, Mick E, Faraone SV, Weber W, Curtis S, Thornell A, Pfister K, Garcia Jetton J, Soriano J. Is ADHD a risk for psychoactive substance use disorders?: Findings from a four-year prospective follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry 1997;36:21-29.

138. Milberger S, Biederman J, Faraone SV, Chen L, Jones J. ADHD is associated with early initiation of cigarette smoking in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 1997;36:37-44.

139. Hirshfeld DR, Biederman J, Brody L, Faraone SV, Rosenbaum, JF. Associations between expressed emotion and child behavioral inhibition: A pilot study. Journal of the American Academy of Child and Adolescent Psychiatry 1997;36:205-213.

140. Biederman, J, Faraone SV, Marrs A, Moore P, Garcia J, Ablon S, Mick E, Gershon J, Kearns ME. Panic disorder and agoraphobia in consecutively referred children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 1997; 36:214-223.

141. Seidman LJ, Biederman J, Faraone SV, Weber W, Mennin D, Jones J. A pilot study of neuropsychological function in girls with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 1997;36:374-383.

142. Biederman J, Faraone SV, Baldessarini RJ, Flood J, Meyer M, Wilens T, Spencer T, Chen L, Weber W. Predicting desipramine levels in children and adolescents: A naturalistic clinical study. Journal of the American Academy of Child and Adolescent Psychiatry 1997;36:384-389.

143. Seidman LJ, Biederman J, Faraone SV, Weber W, Ouellette C. Towards defining a neuropsychology of ADHD: Performance of children and adolescents from a large clinically referred sample. Journal of Consulting and Clinical Psychology 1997;65:150-160.

144. Johnson JE, Cleary J, Ahsan H, Harkavy Friedman J, Malaspina D, Cloninger CR, Faraone SV, Tsuang MT, Kaufmann CA. Anticipation and schizophrenia: Biology or bias? American Journal of Medical Genetics, Neuropsychiatric Genetics 1997;74:275-280.

145. Hirshfeld DR, Biederman J, Brody L, Faraone SV. Rosenbaum JF. Expressed emotion toward children with behavioral inhibition: Associations with maternal anxiety disorder. Journal of the American Academy of Child and Adolescent Psychiatry 1997;36:910-917.

146. Seidman LJ, Goldstein JM, Goodman JM, Koren D, Turner WM, Faraone SV, Tsuang MT. Sex differences in olfactory identification and Wisconsin Card Sorting performance in schizophrenia: Relationship to attention and verbal ability. Biological Psychiatry 1997; 42:104-115.

147. Faraone SV, Biederman J, Garcia Jetton J, Tsuang MT. Attention deficit disorder and conduct disorder: Longitudinal evidence for a familial subtype. Psychological Medicine, 1997;27:291-300.

148. Faraone SV, Biederman J, Wozniak J, Mundy E, Mennin D, O’Donnell D. Is comorbidity with ADHD a marker for juvenile onset mania?: Comparison between childhood And adolescent onset mania In clinically referred children. Journal of the American Academy of Child and Adolescent Psychiatry 1997;36:1046-1055.

149. Faraone SV, Biederman J, Mennin D, Wozniak J, Spencer T. Attention Deficit Hyperactivity Disorder with Bipolar Disorder: A Familial Subtype? Journal of the American Academy of Child and Adolescent Psychiatry 1997;36:1378-1387.

150. Biederman J, Faraone SV, Hatch M, Mennin D, Taylor A, George P. Conduct disorder with and without mania in a referred sample of ADHD children: A preliminary communication. Journal of Affective Disorders 1997;44:177-188.

151. Milberger S, Biederman J, Faraone SV, Chen L, Jones J. Further evidence of an association between attention-deficit/hyperactivity disorder and cigarette smoking. The American Journal on Addictions 1997;6:205-217.

152. Kremen WS, Goldstein JM, Seidman LJ, Toomey R, Lyons MJ, Tsuang MT, Faraone SV. Sex differences in neuropsychological function in nonpsychotic relatives of schizophrenic probands. Psychiatry Research 1997;66:131-144.

153. Faraone SV, Biederman J. Do ADHD and major depression share familial risk factors? Journal of Nervous and Mental Disease 1997;185:533-541.

154. Faraone SV, Biederman J, Mick E. Symptom reports by ADHD adults: Are they influenced by ADHD in their children? Journal of Nervous and Mental Disease 1997;185: 583-584.

155. Greene RW, Biederman JB, Faraone SV, Ouellette CA, Penn C, Griffin SM. Adolescent outcome of ADHD boys with social disability: Results from a four year longitudinal follow-up study. Journal of Consulting and Clinical Psychology 1997;65:758-767.

156. Wozniak J, Biederman J, Faraone SV, Frazier J, Kim J, Millstein R, Gershon J, Thornell A, Cha K, Snyder J. Mania in children with pervasive developmental disorder revisited. Journal of the American Academy of Child and Adolescent Psychiatry 1997;36:1552-1560.

157. Biederman J, Faraone SV, Weber W, Russell R, Rater M, Park KS. Correspondence between DSM-III-R and DSM-IV Attention Deficit/Hyperactivity disorder. Journal of the American Society of Child and Adolescent Psychiatry 1997;36:1682-1687.

158. Lyons MJ, Faraone SV, Tsuang MT, Goldberg J, Eaves LJ, Meyer JM, True WR, Eisen SA. Another view on the 'right' statistical measure of twin concordance. Archives of General Psychiatry 1997;54:1126-1128.

159. Toomey R, Kremen WS, Simpson JC, Samson JA, Seidman LJ, Lyons MJ, Faraone SV, Tsuang MT. Revisiting the factor structure for positive and negative symptoms: Evidence from a large heterogeneous psychiatric sample. American Journal of Psychiatry 1997;154: 371-377.

160. Wilens T, Biederman J, Mick E, Faraone SV, Spencer T. Attention Deficit Hyperactivity Disorder is related to early onset substance abuse. Journal of Nervous and Mental Disease 1997;185:475-482.

161. Seidman LJ, Faraone SV, Goldstein JM, Goodman JM, Kremen WS, Matsuda G, Hoge EA, Kennedy DN, Makris N, Caviness VS, Tsuang MT. Reduced subcortical brain volumes in nonpsychotic siblings of schizophrenic patients: A pilot MRI Study. American Journal of Medical Genetics, Neuropsychiatric Genetics 1997;74:507-514.

162. Milberger S, Biederman J, Faraone SV, Wilens T, Chu M. Associations between ADHD and psychoactive substance use disorders: Findings from a longitudinal study of high-risk siblings of ADHD children. American Journal of Addictions 1997;6:205-217.

163. Faraone SV, Biederman J, Weber W, Russell RL. Psychiatric, Neuropsychological and Psychosocial Features of DSM-IV Subtypes of Attention Deficit Hyperactivity Disorder: Results from a Clinically Referred Sample. Journal of the American Academy of Child and Adolescent Psychiatry 1998;37:185-193.

164. Biederman J, Faraone SV, Taylor A, Sienna M, Williamson S, Fine C. Diagnostic continuity between child and adolescent ADHD: Findings from a longitudinal clinical sample. Journal of the American Academy of Child and Adolescent Psychiatry 1998;37: 305-313.

165. Faraone SV, Biederman J, Mennin D, Russell R. Bipolar and antisocial disorders among relatives of ADHD Children: Parsing familial subtypes of illness. American Journal of Medical Genetics, Neuropsychiatric Genetics 1998;81:108-116.

166. Biederman J, Mick E, Faraone SV. Depression in ADHD children: "True" depression or demoralization. Journal of Affective Disorders 1998;47:113-122.

167. Lyons MJ, Eisen SA, Goldberg J, True W, Lin N, Meyer JM, Toomey R., Faraone SV, Merla-Ramos M., Tsuang MT. A registry based twin study of depression in men. Archives of General Psychiatry 1998;55:468-72.

168. Biederman J, Wilens TE, Mick E, Faraone SV, Spencer T. Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biological Psychiatry 1998;44:269-73.

169. Toomey R, Faraone SV, Simpson JC, Tsuang MT. Negative, positive, and disorganized symptom dimensions in schizophrenia, major depression, and bipolar disorder. Journal of Nervous and Mental Disease 1998; 186; 470-476

170. Koren D, Seidman LJ, Harrison RH, Lyons MJ, Kremen WS, Caplan B, Goldstein JM, Faraone SV, Tsuang MT. Factor structure of the Wisconsin card sorting test: dimensions of deficit in schizophrenia. Neuropsychology 1998;12:289-302.

171. Faraone SV, Matise T, Svrakic D, Pepple J, Malaspina D, Suarez B, Hampe C, Zambuto CT, Schmitt K, Meyer J, Markel P, Lee H, Harkevy-Friedman J, Kaufmann CA, Cloninger CR, Tsuang MT. A genome scan of the European-American schizophrenia pedigrees of the NIMH Genetics Initiative. American Journal of Medical Genetics, Neuropsychiatric Genetics 1998;81:290-295.

172. Cloninger CR, Kaufmann CA, Faraone SV, Malaspina D, Svrakic DM, Harkavy-Friedman J, Suarez BK, Matise TC, Shore D, Lee H, Hampe CL, Wynne D, Drain C, Markel PD, Zambuto CT, Schmitt K, Tsuang MT. A genome-wide search for schizophrenia susceptibility loci: the NIMH genetics initiative & Millennium consortium. American Journal of Medical Genetics, Neuropsychiatric Genetics 1998;81:275-281.

173. Kaufmann CA, Suarez B, Malaspina D, Pepple J, Svrakic DM, Markel PD, Meyer J, Zambuto CT, Schmitt K, Cox-Matise T, Harkavy-Friedman JM, Campe C, Lee H, Faraone SV, Tsuang MT, Cloninger CR. The NIMH Genetics Initiative Millennium schizophrenia consortium: linkage analysis of African-American pedigrees. American Journal of Medical Genetics, Neuropsychiatric Genetics 1998;81:282-289.

174. Leonard S, Gault J, Moore T, Hopkins J, Tobinsion M, Olincy A, Adler LE, Cloninger CR, Kaufmann C, Tsuang MT, Faraone SV, Malaspina D, Svrakic D, Freedman R. Further investigation of a chromosome 15 locus in schizophrenia: Analysis of affected sibpairs from the NIMH Genetics Initiative. The American Journal of Medical Genetics, Neuropsychiatric Genetics 1998;81:308-312.

175. Spencer T, Biederman J, Wilens T, Prince J, Hatch M, Jones J, Harding M, Faraone SV, Seidman L. Effectiveness and tolerability of tomoxetine in adults with childhood onset ADHD. American Journal of Psychiatry 1998;155:693-695.

176. Samuel V, Biederman J, Faraone SV, George P, Mick E, Thornell A, Curtis S, Taylor A, Brome D. Clinical characteristics of ADHD in African-American Children. American Journal of Psychiatry 1998;155:696-698.

177. O’Donnell D, Biederman J, Jones J, Wilens T, Milberger S, Mick E, Faraone SV. Informativeness of child and parent reports of substance use disorders in a sample of ADHD probands, control probands and their siblings. Journal of the American Academy of Child and Adolescent Psychiatry 1998;37:752-758.

178. Toomey R., Faraone SV, Seidman LJ, Kremen WS, Pepple JR, Tsuang MT. Association of vulnerability markers in relatives of schizophrenic patients. Schizophrenia Research 1998;31:89-98.

179. Milberger S, Biederman J, Faraone SV, Jones J. Further evidence of an association between maternal smoking during pregnancy and attention deficit hyperactivity disorder: Findings from a high risk sample of siblings. Journal of Clinical Child Psychology 1998; 27:352-358.

180. Seidman LJ, Biederman J, Weber W, Hatch M, Faraone SV. Neuropsychological functioning in adults with ADHD. Biological Psychiatry 1998;44:260-268.

181. Biederman J, Mick E, Faraone SV. Normalized functioning in youths with persistent ADHD. Journal of Pediatrics 1998;133:544-551.

182. Faraone SV, Biederman J, Mennin D, Russell RL, Tsuang MT. Familial subtypes of attention deficit hyperactivity disorder: A four year follow-up study of children from antisocial-ADHD families. Journal of Child Psychology & Psychiatry 1998;39:1045-1053.

183. Seidman LS, Van Manen K, Turner WM, Gamser DM, Faraone SV, Goldstein JM, Tsuang MT. The effects of increasing resource demand on vigilance performance in adults with schizophrenia or developmental attentional/learning disorders: A preliminary study. Schizophrenia Research 1998;34:101-112.

184. Biederman J, Russell R, Soriano J, Wozniak J, and Faraone S. Clinical features of children with both ADHD and mania: Does ascertainment source make a difference? Journal of Affective Disorders 1998;51:101-112.

185. Kremen WS, Faraone SV, Seidman LJ, Pepple JR, Tsuang MT. Neuropsychological risk indicators for schizophrenia: A preliminary study of female relatives of schizophrenic and bipolar probands. Psychiatry Research 1998;79:227-240.

186. Kremen WS, Faraone SV, Toomey R, Seidman LJ, Tsuang MT. Sex differences in self-reported schizotypal traits in relatives of schizophrenic probands. Schizophrenia Research 1998;34:27-37.

187. Biederman J, Mick E, Bostic JQ, Prince J, Daly J, Wilens TE, Spencer T, Garcia-Jetton J, Russell RL, Wozniak J, Faraone SV. The Naturalistic course of pharmacologic treatment of children with manic-like symptoms: A Systematic chart review. Journal of Clinical Psychiatry 1998;50:628-637.

188. Milberger S, Faraone S, Biederman J, Chu M, Wilens T. Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorders. Archives of Pediatrics & Adolescent Medicine 1998;152:945-951.

189. Samuel V, George P, Thornell A, Curtis S, Taylor A, Brome D, Mick E, Faraone SV, Biederman J. A pilot controlled family study of DSM III-R and DSM-IV ADHD in African-American children. Journal of the American Academy of Child and Adolescent Psychiatry 1999;38:34-39.

190. Wozniak J, Crawford M, Biederman J, Faraone S, Spencer T, Taylor A, Blier H. Antecedents and complications of trauma in ADHD boys: findings from a longitudinal study. Journal of the American Academy of Child and Adolescent Psychiatry 1999;38:48-55.

191. Cohen LG, Biederman J, Wilens T, Spencer TJ, Mick E, Faraone S, Prince J, Flood JG. Desipramine clearance in children and adolescents: Absence of effect of development and gender. Journal of the American Academy of Child and Adolescent Psychiatry 1999;38: 79-85.

192. Faraone SV, Seidman LJ, Kremen WS, Toomey R, Pepple JR, Tsuang MT. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: A four-year follow-up study. Journal of Abnormal Psychology 1999;108:176-181.

193. Wilens TE, Biederman J, March J, Wolkow R, Fine C, Millstein R, Faraone SV, Geller D, Spencer T. Absence of cardiovascular adverse effects of sertraline in children and adolescents. Journal of the American Academy of Child & Adolescent Psychiatry 1999;38:573-577.

194. Tsuang MT, Stone WS, Seidman LJ, Faraone SV, Zimmet S, Wojcik J, Kelleher J, Green AI. Treatment of nonpsychotic relatives of patients with schizophrenia: Four case studies. Biological Psychiatry 1999;41:1412-1418

195. Goldstein JM, Goodman JM, Seidman LJ, Kennedy D, Makris N, Lee H, Tourville J, Caviness VS, Faraone SV, Tsuang MT. Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Archives of General Psychiatry 1999;57:537-548.

196. Faraone SV, Biederman J, Weiffenbach B, Keith T, Chu MP, Weaver A, Spencer T.J., Wilens T.E., Frazier J., Cleves M., and Sakai J. Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. American Journal of Psychiatry 1999;156:768-70.

197. Greene RW, Biederman J, Faraone SV, Wilens TE, Mick E, Blier HK. Further validation of social impairment as a predictor of substance use disorders: Findings from a sample of siblings of boys with and without ADHD. Journal of Clinical Child Psychology 1999;28: 349-354.

198. Spencer T, Biederman J, Coffey B, Geller D, Wilens T, and Faraone S. The 4-year course of tic disorders in boys with attention-deficit/hyperactivity disorder. Archives of General Psychiatry 1999;56:842-847.

199. Biederman J, Faraone SV, Mick E, Williamson S, Wilens T, Spencer T, Weber W, Jetton J, Kraus I, Pert J, Zallen B. Clinical correlates of attention deficit hyperactivity disorder in females: Findings from a large group of pediatrically and psychiatrically referred girls. Journal of the American Academy of Child and Adolescent Psychiatry 1999;38:966-975.

200. Toomey R, Seidman LJ, Lyons MJ, Faraone SV, Tsuang MT. Poor perception of nonverbal social-emotional cues in relatives of schizophrenic patients. Schizophrenia Research 1999;40:121-130.

201. Faraone SV, Meyer J, Matise T, Svrakic D, Pepple J, Malaspina D, Suarez B, Hampe C, Chan G, Aelony A, Schmitt K, Markel P, Lee H, Harkevy-Friedman J, Kaufmann CA, Cloninger CR., Tsuang MT. Suggestive linkage of chromosome 10p to schizophrenia not due to transmission ratio distortion. American Journal of Medical Genetics, Neuropsychiatric Genetics 1999;88:607-608.

202. Seidman LJ, Faraone SV, Goldstein JM, Goodman JM, Kremen WS, Toomey R, Tourville J, Kennedy D, Makris N, Caviness VS, Tsuang MT. Thalamic and amygdala-hippocampal volume reductions in first degree relatives of schizophrenic patients: An MRI-based morphometric analysis. Biological Psychiatry 1999;46:941-54.

203. Biederman J, Faraone SV, Chu MP, Wozniak J. Further evidence of a bidirectional overlap between juvenile mania and conduct disorder in children. Journal of the Americna Academy of Child and Adolescent Psychiatry 1999;38:468-76.

204. Cohen LG, Prince J, Biederman J, Wilens T, Faraone SV, Whitt S, Mick E, Spencer T, Meyer MC, Polisner D, Flood JG. Absence of effect of stimulants on the phamacokinetics of desipramine in children. Pharmacotherapy 1999;19:746-52.

205. Milberger SM, Biederman J, Chu MP, Feighner JA, Faraone SV. Substance use disorder in high-risk adolescent offspring. American Journal on Addictions 1999;8:211-9.

206. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 1999; 104:e20.

207. Tsuang M.T., Lyons M.J., Harley R.M., Xian H., Eisen S.A., Goldberg J., True W., and Faraone S.V. Genetic and environmental influences on transition in drug use. Behavior Genetics, 1999, 29, 473-480.

208. Biederman J, Mick E, Prince J, Bostic JQ, Wilens TE, Spencer T, Wozniak J, and Faraone SV. Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder. Journal of Child and Adolescent Psychopharmacology 1999;9:247-56.

209. Mennin D, Biederman J, Mick E, Faraone SV. Towards defining a meaningful anxiety phenotype for research in ADHD children. Journal of Attention Disorders 2000;3:192-199.

210. Faraone SV, Biederman J, Monuteaux M. Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder. Genetic Epidemiology 2000;18: 1-16.

211. Faraone SV, Biederman J, Friedman D. Validity of DSM-IV subtypes of attention deficit/hyperactivity disorder: A family study perspective. Journal of the American Academy of Child and Adolescent Psychiatry 2000;39:300-307.

212. Lyons MJ, Huppert J, Toomey R, Harley R, JG, Eisen S, True W, Faraone SV, and Tsuang M. Lifetime prevalence of mood and anxiety disorders in twin pairs discordant for schizophrenia. Twin Research, 2000, 3, 28-32.

213. Lunetta KL, Faraone SV, Biederman J, Laird NM. Family-based tests of association and linkage that use unaffected sibs, covariates, and interactions. American Journal of Human Genetics 2000;66:605-610.

214. Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: Impact of remission definition and symptom type. American Journal of Psychiatry 2000;157:816-8.

215. Tsuang MT, Faraone SV, Bingham S, Young K, Prabhudesai S, Haverstock SL, Mena F, Menon S, Pepple J, Johnson J, Baldwin C, Weiss D, Collins J. The Department of Veterans Affairs Cooperative Studies Program Genetic Linkage Study of Schizophrenia: Ascertainment methods and sample description. American Journal of Medical Genetics, Neuropsychiatric Genetics 2000;96:342-347.

216. Faraone SV, Biederman J, Monuteaux MC. Attention deficit disorder and conduct disorder in girls: Evidence for a familial subtype. Biological Psychiatry 2000;48:21-29.

217. Faraone SV, Biederman J, Mick E, Williamson S, Wilens T, Spencer T, Weber W, Jetton J, Kraus I, Pert J, Zallen B. A family study of girls with attention deficit hyperactivity disorder. American Journal of Psychiatry 2000;157:1077-1083.

218. Seidman L, Biederman J, Monuteaux M, Weber W, Faraone SV. Neuropsychological function in non-referred siblings of children with attention deficit hyperactivity disorder: a high risk study. Journal of Abnormal Psychology 2000;109:252-265.

219. Faraone SV, Seidman LJ, Kremen WS, Toomey R, Pepple JR, Tsuang MT. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: The effect of genetic loading. Biological Psychiatry 2000;48:120-126.

220. Fucetola R, Seidman LJ, Kremen WS, Faraone SV, Goldstein JM, Tsuang MT. Age and Neuropsychological Function in Schizophrenia: A Decline in Executive Abilities Beyond that Observed in Healthy Volunteers. Biological Psychiatry 2000;48:137-146.

221. Doyle A, Biederman J, Seidman L, Weber W, Faraone SV. Diagnostic efficiency of neuropsychological test scores for discriminating boys with and without attention deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology 2000;68:477-488.

222. Geller D, Biederman J, Faraone SV, Frazier J, Coffey BJ, Kim G, Bellordre CA. Clinical correlates of obsessive compulsive disorder in children and adolescents referred to specialized and non-specialized clinical settings. Depression and Anxiety 2000;11:163-168.

223. Tsuang MT, Stone WS, Faraone S.V. Towards reformulating the diagnosis of schizophrenia. American Journal of Psychiatry 2000;147:1041-1050.

224. Tsuang MT, Stone WS, and Faraone SV. Towards the prevention of schizophrenia. Biological Psychiatry 2000;48:349-356.

225. Sprich S, Biederman J, Harding, M., Crawford M, Mundy E. and Faraone S.V. Adoptive and biological families of children and adolescents with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 2000;39:1432-1437.

226. Mick E, Biederman J, Jetton J, and Faraone SV. Sleep disturbances associated with attention deficit hyperactivity disorder: The impact of psychiatric comorbidity and pharmacotherapy. Journal of Child and Adolescent Psychopharmacology 2000;10:223-31.

227. Biederman J, Faraone SV, Wozniak J, and Monuteaux MC. Parsing the association between bipolar, conduct, and substance use disorders: a familial risk analysis. Biological Psychiatry 2000;48:1037-44.

228. Kremen WS, Seidman LJ, Faraone SV, Toomey R, and Tsuang MT. The paradox of normal neuropsychological function in schizophrenia. Journal of Abnormal Psychology 2000;109:743-752.

229. Rosenbaum JF, Biederman J, Kagan J, Snidman N, Hirshfeld-Becker DR, Friedman D, Nineberg A, Gallery DJ, and Faraone SV. A controlled study of behavioral inhibition in children of parents with panic disorder and depression. American Journal of Psychiatry 2000;157:2002-2010.

230. Coffey BJ, Biederman J, Spencer T, Geller DA, Faraone SV, and Bellordre CA. Informativeness of structured diagnostic interviews in the identification of Tourette's disorder in referred youth. J Nerv Ment Dis 2000;188:583-8.

231. Biederman J, Mick E, Spencer TJ, Wilens TE, and Faraone SV. Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young. J Child Adolesc Psychopharmacol 2000;10:185-92.

232. Faraone SV, Biederman J, Spencer TJ, and Wilens TE. The drug-placebo response curve: a new method for assessing drug effects in clinical trials. Journal of Clinical Psychopharmacology 2000;20:673-9.

233. Faraone SV, Biederman J, Feighner JA, and Monuteaux MC. Assessing symptoms of attention deficit hyperactivity disorder in children and adults: which is more valid? Journal of Consulting and Clinical Psychology 2000;68:830-42.

234. Biederman J, Faraone SV, Monuteaux MC, and Feighner JA. Patterns of alcohol and drug use in adolescents can be predicted by parental substance use disorders. Pediatrics 2000;106:792-7.

235. Freedman R, Leonard S, Gault J, Moore T, Hopkins J, Cloninger C, Kaufmann C, Tsuang MT, Faraone SV, Malaspina D, Svrakic D, Sanders A, and Gejman P. Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the a7-nicotinic acetylcholine receptor subunit gene (CHRNA7). The American Journal of Medical Genetics, Neuropsychiatric Genetics 2001;105:20-22.

236. Faraone SV, Biederman J, Monuteaux MC. Attention deficit hyperactivity disorder with bipolar disorder in girls: further evidence for a familial subtype? Journal of Affective Disorders 2001;64(1):19-26.

237. Biederman J, Mick E, Faraone SV, Burback M. Patterns of remission and symptom decline in conduct disorder: A four year prospective study of an ADHD sample. Journal of the American Academy of Child and Adolescent Psychiatry 2001;40(3):290-298.

238. Malaspina D, Goetz RR, Friedman JH, Kaufmann CA, Faraone SV, Tsuang M, Cloninger CR, Nurnberger JI, Blehar MC. Traumatic Brain Injury and Schizophrenia in Members of Schizophrenia and Bipolar Disorder Pedigrees. American Journal of Psychiatry 2001;158(3):440-446.

239. Smoller JW, Rosenbaum JF, Biederman J, Susswein LS, Kennedy J, Kagan J, Snidman N, Laird N, Tsuang MT, Faraone SV, Schwarz A, Slaugenhaupt SA. Genetic association analysis of behavioral inhibition using candidate loci from mouse models. American Journal of Medical Genetics 2001;105(3):226-35.

240. Wozniak J, Biederman J, Faraone SV, Blier H, Monuteaux MC. Heterogeneity of childhood conduct disorder: further evidence of a subtype of conduct disorder linked to bipolar disorder. Journal of Affective Disorders 2001;64:121-31.

241. Biederman J, Faraone SV, Hirshfeld-Becker D, Friedman D, Robin JA, and Rosenbaum JF. Patterns of psychopathology and dysfunction in a large controlled study of high risk children of parents with panic disorder and major depression. American Journal of Psychiatry 2001;158(1):49-57.

242. Greene RW, Biederman J, Faraone SV, Monuteaux M., Mick E., DuPre E., Fine C., & Goring J. Social impairment in girls with ADHD: Patterns, gender comparisons, and correlates. Journal of the American Academy of Child and Adolescent Psychiatry, 2001, 40(6); 704-710.

243. Spencer TJ, Biederman J, Faraone SV, Mick E, Coffey B, Geller D, Kagan J, Bearman SK, Wilens T. Impact of tic disorders on ADHD outcome across the life cycle: findings from a large group of adults with and without ADHD. Am J Psychiatry 2001;158:611-7.

244. Spencer T, Biederman J, Heiligenstein J, Wilens T, Faries D, Prince J, Faraone SV, Rea J, Witcher J, & Zeras S. (2001). An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 2001;11: 251-265.

245. Faraone SV, Doyle AE, Mick E, and Biederman J. Meta-analysis of the association between the dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. American Journal of Psychiatry, 2001;158(7):1052-7.

246. Goldstein JM, Seidman LJ, Horton NJ, Makris N, Kennedy DN, Caviness VS, Jr., Faraone SV, Tsuang MT. Normal Sexual Dimorphism of the Adult Human Brain Assessed by In-Vivo Magnetic Resonance Imaging. Cerebral Cortex 2001;11(6):490-497.

247. Spencer TJ, Biederman J, Wozniak J, Faraone SV, Wilens TE, Mick E. Parsing pediatric bipolar disorder from its associated comorbidity with the disruptive behavior disorders. Biological Psychiatry 2001;49(12):1062-70.

248. Faraone SV, Pliszka SR, Olvera RL, Skolnik R, Biederman J. Efficacy of Adderall and methylphenidate in attention deficit hyperactivity reanalysis using drug-placebo and drug-drug response curve methodology. Journal of Child and Adolescent Psychopharmacology 2001;11(2)171-80.

249. Geller DA, Biederman J, Faraone S, Agranat A, Cradock K, Hagermoser L, Kim G, Frazier J, Coffey BJ. Developmental aspects of obsessive-compulsive disorder: findings in children, adolescents, and adults. Journal of Nervous and Mental Disorders. 2001;189(7):471-477.

250. Kremen WS, Seidman LJ, Faraone SV, Tsuang MT. Intelligence quotient and neuropsychological profiles in patients with schizophrenia and in normal volunteers. Biological Psychiatry. 2001;50(6):453-462.

251. Biederman J, Hirshfeld-Becker DR, Rosenblaum JF, Perenick SG, Wood J, Faraone SV. Lack of Association Between Parental Alcohol or Drug Addiction and Behavioral Inhibition in Children. Am J Psychiatry. 2001;158(10):1731-3

252. Faraone SV, Biederman J, Mick E, Doyle AE, Wilens T, Spencer T, Frazier E, Mullen K. A family study of psychiatric comorbidity in girls and boys with attention-deficit hyperactivity disorder. Biol Psychiatry. 2001;50(8):586-592.

253. Biederman J, Monuteaux MC, Green RW, Braaten E, Doyle AE, Faraone SV. Long-term stability of the Child Behavior Checklist in a clinical sample of youth with attention deficit hyperactivity disorder. J Clin Child Psychol. 2001;30(4):492-502.

254. Spencer T, Biederman J, Wilens T, Faraone S, Prince J, Gerard K, Doyle R, Parekh A, Kagan J, Bearman SK. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Archives of General Psychiatry. 2001;58(8):775-782.

255. Spencer T, Biederman J, Coffey B, Geller D, Faraone S, Wilens T. Tourette disorder and ADHD. Advances in Neurology. 2001;85:57-77.

256. Biederman J, Hirshfeld-Bekcer DR, Rosenbaum JF, Herot C, Friedman D, Snidman N, Kagan J, Faraone SV. Further evidence of association between behavioral inhibition and social anxiety in children. Am J Psychiatry. 2001 Oct;158(10):1673-9.

257. Faraone SV, Biederman J, Monuteaux MC, Doyle AE, and Seidman LJ. A Psychometric Measure of Learning Disability Predicts Educational Failure Four Years Later in Boys with Attention Deficit Hyperactivity Disorder. Journal of Attention Disorders 2001;4:220-230.

258. Stone WS, Faraone SV, Seidman LJ, Green AI, Wojcik J, Tsuang MT. Concurrent validation of schizotaxia: A pilot study. Biological Psychiatry. 2001;50(6)434-440.

259. Doyle A, Faraone SV, DuPre EP, Biederman J. Separating attention deficit hyperactivity disorder and learning disabilities in girls: A familial risk analysis. American Journal of Psychiatry. 2001;158(10):166-72.

260. Seidman LJ, Biederman J, Monuteaux MC, Doyle AE, Faraone SV. Learning disabilities and executive dysfunction in boys with attention-deficit/hyperactivity disorder. Neuropsychology 2001;15(4):544-56

261. Braaten EB, Biederman J, DiMauro A, Mick E, Monuteaux MC, Muehl K, Faraone SV. Methodological complexities in the diagnosis of major depression in youth: an analysis of mother and youth self-reports. J Child Adolesc Psychopharmacol. 2001 Winter;11(4):395-407.

262. Frazier JA, Biederman J, Bellordre CA, Garfield SB, Geller B, Coffey BJ, and Faraone S. Should the diagnosis of Attention-Deficit/Hyperactivity Disorder be considered in children with Pervasive Development Disorder? Journal of Attention Disorders 2001;4:203-211.

263. Freedman R, Leonard S, Olincy A, Kaufmann CA, Malaspina D, Cloninger CR, Svrakic D, Faraone SV, Tsuang MT. Evidence for the multigenic inheritance of schizophrenia. Am J Med Genet. 2001 Dec 8;105(8):794-800.

264. Tsuang DW, Skol AD, Faraone SV, Bingham S, Young KA, Prabhudesai S, Haverstock SL, Mena F, Menon AS, Bisset D, Pepple J, Sauter F, Baldwin C, Weiss D, Collins J, Boehnke M, Schellenberg GD, Tsuang MT.Examination of genetic linkage of chromosome 15 to schizophrenia in a large Veterans Affairs Cooperative Study sample. Am J Med Genet. 2001 Dec 8;105(8):662-8.

265. Tsuang MT, Stone WS, Tarbox SI, Faraone SV. An integration of schizophrenia with schizotypy: identification of schizotaxia and implications for research on treatment and prevention. Schizophr Res. 2002 Mar 1;54(1-2):169-75.

266. Geller DA, Biederman J, Faraone SV, Cradock K, Hagermoser L, Zaman N, Frazier JA, Coffey BJ, Spencer TJ. Attention-deficit/hyperactivity disorder in children and adolescents with obsessive-compulsive disorder: fact or artifact? J Am Acad Child Adolesc Psychiatry. 2002 Jan;41(1):52-8.

267. Goldstein JM, Seidman LJ, O'Brien LM, Horton NJ, Kennedy DN, Makris N, Caviness VS Jr, Faraone SV, Tsuang MT. Impact of normal sexual dimorphisms on sex differences in structural brain abnormalities in schizophrenia assessed by magnetic resonance imaging. Arch Gen Psychiatry. 2002 Feb;59(2):154-64.

268. Mick E, Biederman J, Prince J, Fischer MJ, Faraone SV. Impact of Low Birth Weight on Attention-Deficit Hyperactivity Disorder. Journal of Developmental and Behavioral Pediatrics. 2002 Feb; 23(1):16-22.

269. Seidman LJ, Kremen WS, Koren D, Faraone SV, Goldstein JM, and Tsuang MT. A comparative profile analysis of neuropsychological functioning in patients with schizophrenia and bipolar psychoses. Schizophrenia Bulletin. 2002;53 (1-2):31-44.

270. Biederman J, Mick E, Faraone SV, Braaten E, Doyle A, Spencer T, Wilens TE, Frazier E, Johnson MA. Influence of Gender on Attention Deficit Hyperactivity Disorder in Children Referred to a Psychiatric Clinic.Am J Psychiatry. 2002;159 (1):36-42.

271. Mick E, Biederman J, Faraone SV, Sayer J, Kleinman S. Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J Am Acad Child Adolesc Psychiatry. 2002;41(4):378-85.

272. Faraone S, Biederman J. Efficacy of Adderall for Attention-Deficit/Hyperactivity Disorder: A meta-analysis. J Atten Disord. 2002 Aug;6(2):69-75.

273. Faraone SV, Short EJ, Biederman J, Findling RL, Roe C, Manos MJ. Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a drug-placebo and drug-drug response curve analysis of a naturalistic study. Int J Neuropsychopharmacol. 2002 Jun;5(2):121-9.

274. Hirshfeld-Becker DR, Biederman J, Faraone SV, Violette H, Wrightsman J, Rosenbaum JF. Temperamental correlates of disruptive behavior disorders in young children: preliminary findings. Biol Psychiatry. 2002 Apr 1;51(7):563-74.

275. Faraone S, Biederman J, Monuteaux MC. Further evidence for the diagnostic continuity between child and adolescent ADHD. J Atten Disord. 2002;6:5-13.

276. Greene RW, Biederman J, Zerwas S, Monuteaux MC, Goring JC, Faraone SV. (2002). Psychiatric comorbidity, family dysfunction, and social impairment in referred youth with oppositional defiant disorder. Am J Psychiatry. 2002;159:1214-24.

277. Perlis RH, Sachs GS, Lafer B, Otto MW, Faraone SV, Kane JM, Rosenbaum JF. Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data. Am J Psychiatry. 2002;159:1155-9.

278. Spencer T, Biederman J, Coffey B, Geller D, Crawford M, Bearman SK, Tarazi R, Faraone SV. A Double-blind Comparison of Desipramine and Placebo in Children and Adolescents With Chronic Tic Disorder and Comorbid Attention-Deficit/Hyperactivity Disorder. Arch Gen Psychiatry. 2002;59:649-56

279. Wozniak J, Biederman J, Monuteaux MC, Richards J, Faraone SV. Parsing the comorbidity between bipolar disorder and anxiety disorders: a familial risk analysis. J Child Adolesc Psychopharmacol. 2002 Summer;12(2):101-11.

280. Biederman J, Faraone SV, Monuteaux MC. Impact of exposure to parental attention-deficit hyperactivity disorder on clinical features and dysfunction in the offspring. Psychol Med. 2002 Jul;32(5):817-27.

281. Faraone SV, Skol AD, Tsuang DW, Bingham S, Young KA, Prabhudesai S, Haverstock SL, Mena F, Menon AS, Bisset D, Pepple J, Sautter F, Baldwin C, Weiss D, Collins J, Keith T, Boehnke M, Tsuang MT, Schellenberg GD., Linkage of chromosome 13q32 to schizophrenia in a large veterans affairs cooperative study sample. Am J Med Genet. 2002 Aug 8;114(6):598-604.

282. Biederman J, Faraone SV, Monuteaux MC.Differential Effect of Environmental Adversity by Gender: Rutter's Index of Adversity in a Group of Boys and Girls With and Without ADHD. Am J Psychiatry. 2002 Sep;159(9):1556-62.

283. Seidman LJ, Faraone SV, Goldstein JM, Kremen WS, Horton NJ, Makris N, Toomey R, Kennedy D, Caviness VS, Tsuang MT.Left hippocampal volume as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric study of nonpsychotic first-degree relatives. Arch Gen Psychiatry. 2002 Sep;59(9):839-49.

284. Busch B, Biederman J, Cohen LG, Sayer JM, Monuteaux MC, Mick E, Zallen B, Faraone SV.Correlates of ADHD among children in pediatric and psychiatric clinics. Psychiatr Serv. 2002 Sep;53(9):1103-11

285. Faraone SV, Biederman J, Roe C. Comparative Efficacy of Adderall and Methylphenidate in Attention-deficit/Hyperactivity Disorder: A Meta-Analysis. J Clin Psychopharmacol. 2002 Oct;22(5):468-73.

286. Lyons MJ, Bar JL, Kremen WS, Toomey R, Eisen SA, Goldberg J, Faraone SV, Tsuang M. Nicotine and familial vulnerability to schizophrenia: a discordant twin study. J Abnorm Psychol. 2002 Nov;111(4):687-93.

287. Wilcox MA, Faraone SV, Su J, Van Eerdewegh P, Tsuang MT. Genome scan of three quantitative traits in schizophrenia pedigrees.Biol Psychiatry. 2002 Nov 1;52(9):847-854.

288. Tsuang MT, Stone WS, Tarbox SI, Faraone SV. Treatment of nonpsychotic relatives of patients with schizophrenia: Six case studies. Am J Med Genet. 2002 Dec 8;114(8):943-948.

289. Sautter FJ, Cornwell J, Johnson JJ, Wiley J, and Faraone SV. Family history study of posttraumatic stress disorder with secondary psychotic symptoms. Am J Psychiatry 2002;159:1775-7.

290. Spencer TJ, Biederman J, Wilens TE, Faraone SV. Novel treatments for attention-deficit/hyperactivity disorder in children. J Clin Psychiatry. 2002;63 (suppl 12):16-22.

291. Spencer TJ, Biederman J, Wilens TE, Faraone SV. Overview and neurobiology of attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2002;63 (suppl 12):3-9.

292. Wilens TE, Faraone SV, Biederman J, Gunawardene SB. Does Stimulant Therapy of Attention-Deficit/Hyperactivity Disorder Beget Later Substance Abuse? A Meta-analytic Review of the Literature. Pediatrics. 2003 Jan;111(1):179-85.

293. Braaten EB, Beiderman J, Monuteaux MC, Mick E, Calhoun E, Cattan G, and Faraone SV. Revisiting the association between attention-deficit/hyperactivity disorder and anxiety disorders: a familial risk analysis. Biol Psychiatry 2003;53:93-9.

294. Kremen, WS, Seidman, LJ, Faraone, SV, Tsuang, MT. Is there disproportionate impairment in semantic or phonemic fluency in schizophrenia? J Intl Neuropsycho Soc. 2003; Jan(9):79-88.

295. Faraone SV, Monuteaux MC, Biederman J, Cohan SL, Mick E. Does parental ADHD bias maternal reports of ADHD symptoms in children? J Consult Clin Psychol. 2003;Feb;71(1):168-75.

296. Skol AD, Young KA, Tsuang DW, Faraone SV, Haverstock SL, Bingham S, Prabhudesai S, Mena F, Menon AS, Yu CE, Rundell P, Pepple J, Sauter F, Baldwin C, Weiss D, Collins J, Keith T, Boehnke M, Schellenberg GD, Tsuang MT. Modest evidence for linkage and possible confirmation of association between NOTCH4 and schizophrenia in a large veterans affairs cooperative study sample. Am J Med Genet. 2003 Apr 1;118B(1):8-15.

297. Toomey R, Lyons MJ, Eisen SA, Xian H, Chantarujikapong S, Seidman LJ, Faraone SV, Tsuang MT. A twin study of the neuropsychological consequences of stimulant abuse. Arch Gen Psychiatry. 2003 Mar;60(3):303-10.

298. Glatt SJ, Faraone SV, Tsuang MT. Association between a functional catechol o-methyltransferase gene polymorphism and schizophrenia; meta-analysis of case-control and family-based studies. Am J Psychiatry. 2003;Mar;160(3);469-76.

299. Qian Q, Wang Y, Zhou R, Li J, Wang B, Glatt S, Faraone SV. Family-based and case-control association studies of catechol-O-methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism. Am J Med Genet. 2003; April 1;118B(1):103-9.

300. Faraone SV, Seidman LJ, Kremen WS, Kennedy D, Makris N, Caviness VS, Goldstein J, Tsuang MT. Structural brain abnormalities among relatives of patients with schizophrenia: implications for linkage studies. Schizophr Res. 2003 Apr 1;60(2-3):125-40.

301. Geller DA, Coffey B, Faraone S, Hagermoser L, Zaman NK, Farrell CL, Mullin B, Biederman J. Does comorbid attention-deficit/hyperactivity disorder impact the clinical expression of pediatric obsessive-compulsive disorder? CNS Spectr. 2003 Apr;8(4):259-64.

302. Biederman J, Faraone SV, Monuteaux MC, Plunkett EA, Gifford J, Spencer T. Growth deficits and attention-deficit/hyperactivity disorder revisited: impact of gender, development, and treatment. Pediatrics. 2003 May;111(5 Pt 1):1010-6.

303. Mick E, Biederman J, Pandina G, Faraone SV. A preliminary meta-analysis of the child behavior checklist in pediatric bipolar disorder. Biol Psychiatry. 2003 Jun 1;53(11):1021-7.

304. Hirshfeld-Becker DR, Biederman J, Calltharp S, Rosenbaum ED, Faraone SV, Rosenbaum JF. Behavioral inhibition and disinhibition as hypothesized precursors to psychopathology. implications for pediatric bipolar disorder. Biol Psychiatry. 2003 Jun 1;53(11):985-99.

305. Biederman J, Mick E, Wozniak J, Monuteaux MC, Galdo M, Faraone SV. Can a subtype of conduct disorder linked to bipolar disorder be identified? Integration of findings from the Massachusetts General Hospital Pediatric Psychopharmacology Research Program. Biol Psychiatry. 2003 Jun 1;53(11):952-60.

306. Wozniak J, Monuteaux M, Richards J, E Lail K, Faraone SV, Biederman J. Convergence between structured diagnostic interviews and clinical assessment on the diagnosis of pediatric-onset mania. Biol Psychiatry. 2003 Jun 1;53(11):938-44.

307. Doyle AE, Biederman J, Monuteaux M, Cohan SL, Schofield HL, Faraone SV. Diagnostic Threshold For Conduct Disorder In Girls And Boys. J Nerv Ment Dis. 2003 Jun;191(6):379-386.

308. Takahashi S, Cui YH, Kojima T, Han YH, Zhou RL, Kamioka M, Yu SY, Matsuura M, Matsushima E, Wilcox M, Arinami T, Shen YC, Faraone SV, Tsuang MT. Family-based association study of markers on chromosome 22 in schizophrenia using African-American, European-American, and Chinese families. Am J Med Genet. 2003 Jul 1;120B(1):11-7.

309. Takahashi S, Cui Y, Kojima T, Han Y, Yu S, Tanabe E, Yara K, Matsuura M, Matsushima E, Nakayama J, Arinami T, Shen Y, Faraone SV, Tsuang MT. Family-based association study of the NOTCH4 gene in schizophrenia using Japanese and Chinese samples. Biol Psychiatry. 2003 Jul 15;54(2):129-35.

310. Glatt SJ, Faraone SV, Tsuang MT. CAG-Repeat length in exon 1 of KCNN3 does not influence risk for schizophrenia or bipolar disorder: a meta-analysis of association studies. Am J Med Genet. 2003 Aug 15;121B(1):14-20.

311. Glatt SJ, Faraone SV, Tsuang MT. Schizophrenia is not associated with DRD4 48-base-pair-repeat length or individual alleles: results of a meta-analysis. Biol Psychiatry. 2003 Sep 15;54(6):629-35.

312. Seidman LJ, Landa M, Kremen WS, Faraone SV, Tsuang MT. Organizational and visual memory deficits in schizophrenia and bipolar psychoses using the Rey-Osterrieth Complex Figure: Effects of duration of illness. J Clin Exp Neuropsychol. 2003 Oct;25(7):949-64.

313. Faraone SV, and Wilens T. Does stimulant treatment lead to substance use disorders? J Clin Psychiatry 2003;64 Suppl 11:9-13.

314. Doyle AE, Biederman J, Monuteaux M, Cohan SL, Schofield HL, and Faraone SV. Diagnostic threshold for conduct disorder in girls and boys. J Nerv Ment Dis 2003;191:379-86.

315. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, Brzustowicz LM, Kaufmann CA, Garver DL, Gurling HM, Lindholm E, Coon H, Moises HW, Byerley W, Shaw SH, Mesen A, Sherrington R, O'Neill FA, Walsh D, Kendler KS, Ekelund J, Paunio T, Lonnqvist J, Peltonen L, O'Donovan MC, Owen MJ, Wildenauer DB, Maier W, Nestadt G, Blouin JL, Antonarakis SE, Mowry BJ, Silverman JM, Crowe RR, Cloninger CR, Tsuang MT, Malaspina D, Harkavy-Friedman JM, Svrakic DM, Bassett AS, Holcomb J, Kalsi G, McQuillin A, Brynjolfson J, Sigmundsson T, Petursson H, Jazin E, Zoega T, and Helgason T. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 2003;73:34-48.

316. Glatt SJ, Faraone SV, Tsuang MT. Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia. Mol Psychiatry. 2003 Nov;8(11):911-5

317. Mick E, Biederman, J, Faraone SV, Murray K. and Wozniak J. Defining a developmental subtype of bipolar disorder in a sample of non-referred adults by age at onset. J Child Adol Psychopharmy. 2003; 13 (3):785-790.

318. Stewart SE, Geller DA, Jenike M, Pauls D, Shaw D, Mullin B, and Faraone SV. Long term outcome of pediatric obsessive compulsive disorder: a meta-analysis and qualitative review of the literature. Acta Psychiatr Scand 2004;190:1-10.

319. Lowe N, Kirley A, Hawi Z, Sham P, Wickham H, Kratochvil CJ, Smith SD, Lee S Y, Levy F, Kent L, Middle F, Rohde LA., Roman T, Tahir E, Yazgan Y, Asherson P, Mill J, Thapara A, Payton A, Todd RD, Stephens T, Ebstein RP, Mano I, Barr CL, Wigg KG, Sinke RJ, Buitelaar JK, Smalley SL, Nelson SF, Biederman J, Faraone SV, Gill M. Joint Analysis Of DRD5 Marker Concludes Association with ADHD Confined to the Predominantly Inattentive and Combined Subtypes. Am J Human Genetics. 2004 Feb; 74(2) 348-356.

320. Faraone SV, Spencer T, Aleardi M, Pagano C, and Biederman J. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2004 Feb; 24(1):24-9.

321. Mick E, Biederman J, Faraone SV, Murray K, Wozniak J. Defining a developmental subtype of bipolar disorder in a sample of nonreferred adults by age at onset. J Child Adolesc Psychopharmacol. 2003 Winter;13(4):453-62.

322. Seidman LJ, Pantelis C, Keshavan MS, Faraone SV, Goldstein JM, Horton NJ, Makris N, Falkai P, Caviness VS, Tsuang MT. A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric family study of the parahippocampal gyrus. Schizophr Bull. 2003;29(4):803-30.

323. Hirshfeld-Becker DR, Biederman J, Faraone SV, Segool N, Buchwald J, Rosenbaum JF. Lack of association between behavioral inhibition and psychosocial adversity factors in children at risk for anxiety disorders. Am J Psychiatry. 2004 Mar;161(3):547-55.

324. Abdolmaleky, H. M., Faraone, S. V., Glatt, S. J., & Tsuang, M. T.. Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia. Schizophr Res 2004;67:53-62.

325. Faraone, S. V., Glatt, S. J., Su, J., & Tsuang, M. T. Three potential susceptibility Loci shown by a genome-wide scan for regions influencing the age at onset of mania. Am J Psychiatry 2004;161:625-30.

326. Thermenos HW, Seidman LJ, Breiter H, Goldstein JM, Goodman JM, Poldrack R, Faraone SV, and Tsuang MT. Functional magnetic resonance imaging during auditory verbal working memory in nonpsychotic relatives of persons with schizophrenia: a pilot study. Biol Psychiatry 2004;55:490-500.

327. Biederman, J., Faraone, S. V., Monuteaux, M. C., Bober, M., & Cadogen, E. Gender effects on Attention-Deficit/Hyperactivity disorder in adults, revisited. Biol Psychiatry 2004;55:692-700.

328. Yang L, Wang YF, Qian QJ, Biederman J, Faraone SV. DSM-IV subtypes of ADHD in a Chinese outpatient sample. J Am Acad Child Adolesc Psychiatry 2004 Mar; 43(3):248-50.

329. Stone WS, Faraone SV, Su J, Tarbox SI, Van Eerdewegh P, Tsuang MT. Evidence of linkage between regulatory enzymes in glycolysis and schizophrenia in a multiplex sample. Am J Med Genet. 2004;128B(1):5-10.

330. Hirshfeld-Becker DR, Biederman J, Faraone SV, Robin JA, Friedman D, Rosenthal JM, Rosenbaum JF. Pregnancy complications associated with childhood anxiety disorders. Depress Anxiety 2004;19(3):152-62.

331. Biederman J, Petty C, Faraone SV, Hirshfeld-Becker D, Pollack MH, Henin A, Gilbert J, Rosenbaum JF. Moderating effects of major depression on patterns of comorbidity in patients with panic disorder. Psychiatry Res. 2004 Apr 30;126(2):143-9.

332. Glatt SJ, Faraone SV, Tsuang MT. DRD2-141C Insertion/Deletion Polymorphism is not Associated with Schizophrenia: Results of a Meta-Analysis. Am J Med Genet (Neuropsych Genetics) 2004; 128B(1) :21-23.

333. Qian Q, Wang Y, Zhou R, Yang L, Faraone SV. Family-based and case-control association studies of DRD4 and DAT1 polymorphisms in Chinese attention deficit hyperactivity disorder patients suggest long repeats contribute to genetic risk for the disorder. Am J Med Genet 2004; 128B(1): 84-89.

334. Biederman J, Petty C, Faraone S, Seidman L. Phenomenology of childhood-onset psychosis: findings from a large sample of psychiatrically referred youth. J Nerv Ment Dis. 2004 Sep;192(9):607-614.

335. Yang Li, Wang Yu-Feng, Li Jun, Faraone SV. Association of the Norepinephrine Transporter Gene (NET) with Methylphenidate Response J Am Acad Child Adolesc Psychiatry 2004; Sep 43(9):1154-1158.

336. Palumbo D, Spencer T, Lynch J, Co-Chien H, Faraone SV. Emergence of Tics in Children with ADHD: Impact of Once-Daily OROS® Methylphenidate Therapy . J Child Adol Psychopharm. Summer 2004; 14(2) (185-94).

337. Cohen LS, Altshuler LL, Stowe ZN, and Faraone SV. Reintroduction of antidepressant therapy across pregnancy in women who previously discontinued treatment. A preliminary retrospective study. Psychother Psychosom, 2004;73:255-8.

338. Biederman J, Faraone S, Monuteaux M and Grossbard J. How Informative Are Parent Reports of ADHD Symptoms for Assessing Outcome in Clinical Trials? A Pooled Analysis of Parents' and Teachers' Reports. Pediatrics 2004;Jun;113(6):1667-71.

339. Biederman J, Monuteaux MC, Doyle AE, Seidman LJ, Wilens TE, Ferrero F, Morgan CL, FAraone SV. Impact Of Executive Function Deficits And Attention-Deficit/Hyperactivity Disorder (ADHD) On Academic Outcomes In Children. J Consult Clin Psychol 2004 Oct:72(5):757-766.

340. Biederman J, Monuteaux M, Faraone SV, Hirshfield-Becker D, Henin A, Gilbert J, and Rosenbaum J. Does referral bias impact findings in high-risk offspring for anxiety disorders? A controlled study of high risk children of non-referred parents with panic disorder/agoraphobia and major depression. J Affect Disord 2004 Oct 15;82(2)209-216.

341. Biederman J, Mick E, Faraone SV, Van Patten S, Burback M, Wozniak J. A prospective follow-up study of pediatric bipolar disorder in boys with attention-deficit/hyperactivity disorder. J Affect Disorder 2004 Oct:82(Supple) S17-S23.

342. Biederman J, Faraone S, Wozniak J, Mick E, Kwon A, Aleardi M. Further evidence of unique developmental phenotypic correlates of pediatric bipolar disorder: findings from a large sample of clinically referred preadolescent children assessed over the last 7 years. J Affect Disorder 2004 Oct:82(Supple) S45-S58.

343. Faraone SV, Su J, Tsuang MT. A Genome-wide scan of symptom dimensions in bipolar disorder pedigrees of adult probands. J Affect Disorders 2004 Oct;82(Suppl):S71-S78.

344. Coffey BJ, Biederman J, Geller D, Frazier J, Spencer T, Doyle R, Gianinin L, Small A, Frisone DF, Magovcevic M, Stein N, Faraone SV. Reexamining Tic Persistence and Tic-Associated Impairment in Tourette’s Disorder: Findings From a Naturalistic Follow-Up Study. J Nerv Ment Dis. 2004 Nov;192(11):776-780.

345. Wilens T, Biederman J, Kwon A, Ditterline J, Forkner P, Chase R, Moore H, Swezey A, Snyder L, Morris M, Henin A, Wozniak J, Faraone SV, Risk for substance use disorders in adolescents with bipolar disorder. Journal of American Academy Child and Adolescent Psychiatry. 2004 Nov;43(11):1380-1386.

346. Kremen WS, Seidman L, Faraone SV, Toomey R, Tsuang MT. Heterogeneity of schizophrenia: A study of individual neuropsychological profiles. Schizophrenia Research 2004 Dec 1;71(2-3):307-321.

347. Biederman J, Kwon A, Wozniak J, Mick E, Markowitz S, Fazio V, Faraone SV. Absence of Gender Differences in Pediatric Bipolar Disorder: Findings from a Large Sample of Referred Youth. Journal of Affective Disorders. 2004;83(2-3):207-214.

348. Faraone SV, Spencer T, Montano CB , Biederman J: Attention Deficit Hyperactivity Disorder in Adults: A Survey of Current Practice in Psychiatry and Primary Care. Archives of Internal Medicine 2004;164:1221-1226.

349. Lyons, M J, Koenen, Koenen KC, Buchting, F, Meyer JM, Eaves L, Toomey R, Eisen SA, Goldberg J, Faraone SV, Ban RJ, Jerskey B, Tsuang MT. "A twin study of sexual behavior in men." Arch Sex Behav 2004; 33(2): 129-36.

350. Geller D, Biederman J, Faraone S, Spencer T, Doyle R, Mullin B, Magovcevic M, Zaman N, Farrell C. Re-examining Comorbidity of Obsessive Compulsive and Attention-Deficit/Hyperactivity Disorder Using an Empirically Derived Taxonomy, European Child and Adolescent Psychiatry 2004;13(2): 83-91.

351. Faraone SV, Su J, Taylor L, Wilcox M, Van Eerdewegh P, and Tsuang MT. A novel permutation testing method implicates sixteen nicotinic acetylcholine receptor genes as risk factors for smoking in schizophrenia families. Hum Hered. 2004;57(2):59-68.

352. Adler LA, Spender T, Faraone SV, Reimherr F, Kelsey D, Michelson D, Biederman J. Training Raters to Assess Adult ADHD: Reliability of Ratings. Journal of Attention Disorders 2005; Feb;8(3):121-6.

353. Gamma F, Faraone SV, Glatt SJ, Yeh Y-C, Tsuang MT. Schizophrenia is not associated with the 40-Base-Pair Repeat Polymorphism of the Dopamine Transporter Gene (SLC6A3): A Meta-analysis of Association. Schizophrenia Research. 2005 Feb 1;73(1):55-58.

354. Monuteaux M, Faraone SV, Herzig K, Navsaria N, Biederman J. Attention-deficit/hyperactivity disorder and dyscalculia evidence for independent familial transmission. J. Learn. Disabil., 2005, 38, 1-96.

355. Abdolmaleky HM, Cheng K-H; Russo A, Smith CL, Faraone SV, Wilcox M, Shafa R, Glatt S, Nguyen G, Ponte JF, Thiagalingam S, Tsuang MT. Hypermethylation of the Reelin (RELN) Promoter in the Brain of Schizophrenic Patients: A Preliminary Report. Am J Med Gen (Neuropsych Genetics). 2005 April; 134B(1):60-66.

356. Biederman J, Mick E, Wozniak J, Aleardi M, Spencer T, Faraone SV. An Open-Label Trial of Risperidone in Children and Adolescents with Bipolar Disorder. J Child Adolesc Psychopharmacol. 2005; 15(2):311-317.

357. Faraone SV, Biederman J, Monuteaux M, Spencer T. Long-term effects of extended release mixed amphetamine salts treatment of ADHD on growth. Journal of Child and Adolescent Psychopharmacology 2005; 15(2):191-202.

358. McGrath M, Sullivan M, Devin J, Fontes-Murphy M, Barcelos S, Depalma J, Faraone S. Early precursors of low attention and hyperactivity in a preterm sample at age four. 2005. Issues Compr Pediatr Nurs 28(1):1-15.

359. Spencer T, Biederman J, Wilens TE, Doyle R, Surman C, Price JB, Mick E, Aleardi M, Herzig K, Faraone SV. A Large Double Blind Randomized Clinical Trial of Methylphenidate in the Treatment of Adults with ADHD. Biological Psychiatry 2005;57(5):456-63.

360. Smoller JW, Ymaki LH, Fagerness JA, Biederman J, Racette S, Laird NM, Kagan J, Snidman N, Faraone SV, Hirshfeld-Becker D, Tsuang MT, Slaugenhaupt SA, Rosenbaum JF, Sklar PB. The Corticotropin-Releasing Hormone Gene and Behavioral Inhibition in Children at Risk for Panic Disorder. Biol Psychiatry. 2005 Jun 15;57(12):1485-1492.

361. Doyle AE, Faraone SV, Seidman LJ, Willcutt EG, Nigg JT, Waldman ID, Pennington BF, Peart J, Biederman J. Are endophenotypes based on measures of executive functions useful for molecular genetic studies of ADHD? J Clin Psychol Psychiatry. 2005;Jul; 46(7):774-803.

362. Kessler RC, Adler LA, Barkley R, Biederman J, Conners CK, Faraone SV, Greenhill LL, Jaeger S, Seenik K, Spender T, Ustun TB, Zaslavsky AM. Patterns and predictors of attention-deficit hyperactivity disorder persistence into adulthood: results from the national commorbidity survey replication. Biol Psychiatry 2005 June 1;57(11):1442-51.

363. Li J, Wang Y, Zhou R, Zhang H, Yang L, Wang B and Faraone SV.Serotonin 5-HT1B Receptor Gene and Attention Deficit Hyperactivity Disorder in Chinese Han Subjects. American Journal of Medical Genetics (Neuropsychiatric Genetics) 2005;132(1):59-63.

364. Seidman L, Biederman J, Monuteaux M, Valera M, Doyle A, Faraone, SV. Impact of Gender and Age on Executive Functioning: Do Girls and Boys with and without Attention-Deficit/Hyperactivity Disorder Differ Neuropsychologically in Pre-Teen and Teenage Years? Developmental Neuropsychology 2005; 27(1):79-105.

365. Lasky-Su JA, Faraone SV, Glatt SJ, Tsuang MT. Meta-Analysis of the Association between Two Polymorphisms in the Serotonin Transporter Gene and Affective Disorders. American Journal of Medical Genetics (Neuropsychiatric Genetics) 2005;133(1):110-5.

366. Biederman J, Petty C, Faraone SV, Hirshfeld-Becker DR, Henin A, Pollack MH, Rosenbaum JF. Patterns of comorbidity in panic disorder and major depression: findings from a nonreferred sample. Depression and Anxiety 2005; 21(2):55-60.

367. Doyle AE, Willcutt EG, Seidman LJ, Biederman J, Chouinard VA, Silva J, Faraone SV. Attention-deficit/hyperacitivity disorder endophenotypes. Biol Pscyh 2005 June 1;57(22):1324-35.

368. Spencer TJ, Biederman J, Madras BK, Faraone SV, Dougherty DD, Bonab AA, Fischman AJ. In vivo neroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter. Biol Psych. 2005 June 1;57(11):1293-300.

369. Biederman J, Kwon A, Aleardi M, Chouinard V, Marino T, Cole H, Mick E, Faraone SV. Absence of gender effects on attention-deficit/hyperactivity disorder: Findings in a non-referred sample. Am J. Psych. 2005. 162(6):1083-9.

370. Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, Howes MJ, Jin R, Secnik K, Spencer T, Ustun TB, Walters EE. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. 2005. Psychol Med;35:245-56.

371. Wilens T, Hahesy A, Biederman J, Bredin E, Tanguay S, Kwon A and Faraone SV: Influence of Parental SUD and ADHD on ADHD in their offspring: Preliminary Results from a Pilot Controlled Family Study. Am. J. Addict. 2005 Mar-Apr;14(2):179-87.

372. Biederman J, Faraone SV, Wozniak J, Mick E, Kwon A, Cayton GA, Clark SV. Clinical correlates of bipolar disorder in a large, referred sample of children and adolescents. J Psychiatr Res. 2005; Jul 8.

373. Faraone, SV, Perlis RH, Doyle AE, Smoller JE, Goralnick JJ, Holmgren MA, Sklar P. Molecular genetics of attention deficit hyperactivity disorder. Biological Psychiatry 2005;57:1313-1323.

374. Faraone SV. Predicting the safety of medications used to treat psychiatric disorders in Children: The problem of rare adverse events. Contemp Pediatr (In Press).

375. Wilens T, Kwon A, Faraone S, Tanguay S, Chase R, Biederman J. Adults with ADHD plus substance abuse: impact on comorbidity. Am J Addiction. (In Press).

376. Kremen WS, Lyons MJ, Boake C, Xian H, Jacobsen KC, Waterman B, Eisen SA, Goldberg J, Faraone SV, Tsuang MT. A discordant twin study of premorbid cognitive ability in schizophrenia. Journal of Clinical and Experimental Neuropsychology (In Press).

377. Glatt, SJ, Wang, RS, Yeh, YC, Tsuang, MT and Faraone, S.V. Five NOTCH4 Polymorphisms show Weak Evidence for Association with Schizophrenia: Evidence from Meta-Analyses, Schizophrenia Research. (In Press).

378. Faraone SV, Biederman J, Zimmerman B. Are Teacher Reports Needed to Modulate Dosing and Monitor Responses to Therapy in Children with ADHD?” European Journal of Child and Adolescent Psychiatry. (In Press)

379. Biederman J, Petty C, Faraone S, Hirshfeld-Becker DR, Henin A, Rauf A, Scott M, Pollack M , Rosenbaum J: Childhood antecedents to panic disorder: An empirically derived analysis in referred and non-referred samples. J Child Adolesc Psychopharmacol. (In Press).

380. Sun L, Jin Z, Zang Y-F, Zeng Y-W, Liu G, Li Y, Seidman LJ, Faraone SV, Wang Y-F. Differences between Attention-deficit Disorder with and without hyperactivity: A Preliminary 1H-magnetic resonance spectroscopy study. Brain Development. 2005 Aug;27(5):340-4.

381. Hammerness P, Monteaux M, Faraone SV, Biederman J. Re-examining the association between childhood asthma and attention deficit hyperactivity disorder. Journal of Attention Disorders. (In Press)

382. Hudziak JJ, Althoff RR, Rettew DC, Derks EM, Faraone SV, Boomsma DI. The Prevalence and Genetic Architectures of CBCL-Juvenile Bipolar Disorder. Biological Psychiatry (In Press).

383. Doyle AE, Biederman J, Seidman L, Goralnick J, Faraone SV. Neuropsychological Functioning in Relatives of Girls With and Without ADHD. Psychological Medicine (In Press).

384. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM. The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. American Journal of Psychiatry (In Press).

385. Faraone SV, Biederman J, Mick E. The Age Dependent Decline Of Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Follow-Up Studies, Psychological Medicine (In Press)

386. Stone WS, Faraone SV, Seidman LJ, Olson EA, Tsuang MT. Searching for the Liability to Schizophrenia: Concepts and Methods Underlying Genetic High-Risk Studies of Adolescents. Journal of Child and Adolescent Psychopharmacology (In Press).

387. Faraone SV, Asherson P, IMAGE Consortium. The Molecular Genetics of Attention Deficit Hyperactivity Disorder: A View from the IMAGE Project. Psychiatric Times (In Press).

388. Staller J, Faraone SV. Attention-Deficit Hyperactivity Disorder in Girls: Epidemiology and Management: Epidemiology and Management. CNS Drugs (In Press).

389. Faraone SV, Skol AD, Tsuang DW, Young KA, Haverstock SL, Prabhudesai S, Mena F., Menon A S, Leong L, Sautter F, Baldwin C, Bingham S, Weiss D, Collins J, Keith T, vanden Eng JL, Boehnke M, Tsuang MT, Schellenberg GD Genome Scan of Schizophrenia Families in a Large Veterans Affairs Cooperative Study Sample: Evidence for Linkage to 18p11.32 and for Racial Heterogeneity on Chromosomes 6 and 14. American Journal Medical Genetics (Neuropsychiatric Genetics). (In Press).

390. Biederman J, Petty C, Faraone SV, Hirshfeld-Becker DR, Henin A, Doughtery M, LeBel T, Pollack M, Rosenbaum J. Parental predictors of pediatric panic disorder/agoraphobia: A controlled study in high risk offspring. Depression and Anxiety (In Press).

Reviews, Chapters, Letters, and Editorials 1. Faraone SV. Psychiatry and political repression in the Soviet Union. American Psychologist 1982;37:1105-

1112.

2. Curran JP, Faraone SV, Dow G. Psychosocial treatment of schizophrenia. In: Hersen M, editors. Practice of Inpatient Behavior Therapy: Clinical Guide. New York, NY: Grune and Stratton;1985.

3. Faraone SV, Tsuang MT. Quantitative models of the genetic transmission of schizophrenia. Psychological Bulletin 1985;98:41-66.

4. Faraone SV, Tsuang MT. Comment on possible autoimmune mechanisms in schizophrenia. Journal of Integrative Psychiatry 1985;3:140-141. [Invited Commentary]

5. Curran JP, Faraone SV, Graves D. Behavioral family therapy in an acute inpatient setting. In: Falloon IA, editor. Handbook of Behavioral Family Therapy. New York, NY: Guilford;1986.

6. Curran JP, Sutton RG, Faraone SV, Guenette S. Inpatient approaches. In: M. Hersen, A.S. Bellak, editors. Handbook of Clinical Behavior Therapy. New York, NY: Plenum; 1986.

7. Brown WA, Faraone SV. Neuroleptic bioavailability as a predictor of relapse. In: Lieberman JA, editor. Prediction of Relapse in Schizophrenia. Washington DC:American Psychiatric Press;1986.

8. Tsuang MT, Lyons MJ, Faraone SV. Problems of diagnosis in family studies. Journal of Psychiatric Research 1987;21:391-399.

9. Tsuang MT, LyonsMJ, Faraone SV. The contribution of genetic research to diagnostic issues in schizophrenia. In: Helmchen H, Henn F, editors. Biological Perspectives of Schizophrenia. Chichester, U.K.: John Wiley;1987.

10. Faraone SV, Lyons MJ, Tsuang MT. Schizophrenia: Mathematical models of genetic transmission. In: Tsuang MT, Simpson JC, editors. Handbook of Schizophrenia Volume 3: Nosology, Epidemiology and Genetics. Amsterdam, Holland:Elsevier;1988.

11. Tsuang MT, Faraone SV, Day M. The schizophrenic disorders. In: AM Nicholi, editor. The Harvard Guide to Modern Psychiatry. Cambridge MA:Belknap Press;1988.

12. Faraone SV. Psychology's role in the campaign to abolish torture: Can individuals and organizations make a difference. In: Suedfeld P, editor. Psychology and Torture. Washington, D.C.: Hemisphere: New York, NY;1990.

13. Kremen WS, Faraone SV, Tsuang MT. Schizophrenic disorders. In: Hyman S, Jennike M, editors. Manual of Clinical Problems in Psychiatry. Boston, MA: Little Brown; 1990.

14. Biederman J, Faraone SV. Attention Deficit Hyperactivity Disorder: Family-Genetic Risk Factors and Comorbidity. In: Amir N, Rapin I, Branski D, editors. Pediatric Neurology: Behavior and Cognition in the Child with Brain Dysfunction. Basel:Karger; 1991.

15. Tsuang MT, Gilbertson MW, Faraone SV. Genetic transmission of negative and positive symptoms in the biological relatives of schizophrenics. In: Marneros A, Tsuang MT, Andreasen N, editors. Positive vs. Negative Schizophrenia. New York, NY: Springer-Verlag;1991.

16. Faraone SV, Santangelo S. Methods in genetic epidemiology. In: Fava M, Rosenbaum JF, editors. Research Designs and Methods in Psychiatry. Amsterdam, The Netherlands:Elsevier;1992.

17. Biederman J, Faraone SV. Lapey K. Comorbidity of Diagnosis in Attention Deficit Hyperactivity Disorder. In: Weiss G, editor. Child and Adolescent Psychiatric Clinics of North America (Volume 1 #2): Attention Deficit Hyperactivity Disorder. Philadelphia: WB Saunders;1992.

18. Tsuang MT, Lyons MJ, Faraone SV. Clinical phenotypes: Problems in diagnosis. In: the Proceedings of the Münchener Genetikgesprachäche, C.I.N.P. President’s Workshop: Genetic Research in Psychiatry. New York, NY: Springer-Verlag; 1992, pp. 173-192.

19. Biederman J, Rosenbaum J, Bolduc-Murphy EA, Faraone SV, Chaloff J, Hirshfeld DR, Kagan J. Behavioral Inhibition as a Temperamental Risk Factor for Anxiety Disorders. In: H Leonard, editor. Child and Adolescent Psychiatric Clinics of North America, Disruptive Behavior Disorders (Volume 2 #4): Anxiety Disorders. Philadelphia: W. B. Saunders;1993.

20. Tsuang MT, Faraone SV. Neuropsychiatric genetics: A new specialty section of the American Journal of Medical Genetics. American Journal of Medical Genetics, Neuropsychiatric Genetics 1993;48:1-3. [Editorial].

21. Tsuang MT, Faraone SV, Lyons MJ. Recent advances in psychiatric genetics. In: Costa e Silva JA, Nadelson CC (Volume eds) Andreasen NC, Sato M (Section eds). International Review of Psychiatry, Volume 1. Washington, D.C.: American Psychiatric Press;1993.

22. Faraone SV, Biederman J. Is attention deficit hyperactivity disorder familial? Harvard Review of Psychiatry 1994;1:271-287.

23. Tsuang MT, Faraone SV. The genetic epidemiology of schizophrenia. Comprehensive Therapy 1994;20:130-135.

24. Tsuang MT, Faraone SV, Green RR. Genetic epidemiology of mood disorders. In: Papolos DF, Lachman HM, editors. Genetic Studies in Affective Disorders: Overview of Basic Methods, Current Directions and Critical Research Issues. New York, NY: John Wiley & Sons;1994.

25. Kremen WS, Seidman LJ, Pepple JR, Lyons MJ, Tsuang MT, Faraone SV. Neuropsychological risk indicators for schizophrenia: A review of family studies. Schizophrenia Bulletin 1994;20:103-120.

26. Spencer T, Biederman J, Wilens T, Faraone SV. Is attention deficit hyperactivity disorder in adults a valid disorder? Harvard Review of Psychiatry 1994;1:326-335.

27. Tsuang MT, Faraone SV. Schizophrenia. In: Winokur G, Clayton P, editors. Medical Basis of Psychiatry, Second Edition. Philadelphia, PA: W. B. Saunders;1994.

28. Faraone SV, Biederman J. Genetics of Attention Deficit Hyperactivity Disorder. In: Greenhill L, editor. Child and Adolescent Psychiatric Clinics of North America: Disruptive Behavior Disorders. Philadelphia, PA: W. B. Saunders;1994.

29. Faraone SV. Review of “Genetic Approaches to Mental Disorders”. Gershon E, Cloninger CR. editors. Journal of Nervous and Mental Disease 1995;183:189. [Invited Book Review].

30. Biederman J, Faraone SV. Childhood mania revisited. Israel Journal of Medical Sciences 1995;31:647-651.

31. Tsuang MT, Faraone SV. Genetic heterogeneity of schizophrenia. Psychiatrica et Neurologica Japonica 1995;97:485-501.

32. Faraone SV, Tsuang MT. Methods in Psychiatric Genetics. In: Tohen M, Tsuang MT, Zahner GEP, editors. Textbook in Psychiatric Epidemiology. NY: John Wiley;1995.

33. Tsuang MT, Faraone SV. Epidemiology and Behavioral Genetics of Schizophrenia. In: SJ Watson, editor. Biology of Schizophrenia and Affective Disease. Washington DC: American Psychiatric Press;1996, p.163-195.

34. Tsuang MT, Faraone SV. Genetics of Alzheimer’s Disease. Journal of the Formosan Medical Association 1996;95:733-740. [Invited Review].

35. Biederman J, Faraone SV, Kiely K. Comorbidity of Childhood Disorders. In: Hechtman L, editor. Do They Outgrow It? Long Term Outcome of Childhood Disorders. Washington DC:American Psychiatric Press; pp 39-76, 1996.

36. Faraone SV. Commentary: Genetic Influence on Attention Problems in a General Population Twin Sample. Journal of the American Academy of Child and Adolescent Psychiatry 1996;35:596-598. [Invited Commentary].

37. Biederman J, Faraone SV. Attention Deficit Hyperactivity Disorder. The Harvard Neuroscience Newsletter: On the Brain. Winter 1996. [Invited Review].

38. Faraone SV. Attention Deficit Hyperactivity Disorder in Adults. Clinical Advances in the Treatment of Psychiatric Disorders, January/February 1996;10:4-6. [Invited Review].

39. Faraone SV, Biederman J, Kiely KK. Cognitive Functioning, Learning Disability and School Failure in Attention Deficit Hyperactivity Disorder. In Beitchman J, Cohen N, Konstantareas MM, Tannock R, editors. Language, Learning and Behavior Disorders. New York, N.Y.: Cambridge University Press;1996.

40. Tsuang MT, Faraone SV. The Inheritance of Mood Disorders. In Hall LL, editor. Genetics and Mental Illness: Evolving Issues for Research and Society. New York: Plenum;1996.

41. Biederman J, Wilens TE, Spencer TJ, Faraone SV, Mick E, Ablon JS, Kiely K. Diagnosis and treatment of adults with attention deficit hyperactivity disorder (ADHD). In: Pollack MH, Otto MW, Rosenbaum JF, editors. Challenges in psychiatric treatment: Pharmacologic and psychosocial strategies. New York: Guilford Press; 1996.

42. Samuel V, Curtis S, Thornell A, George P, Taylor A, Brome D, Biederman J, Faraone SV. The unexplored void of ADHD and African-American research: A review of the literature. Journal of Attention Disorders 1997;1:197-208.

43. Faraone SV, Gottesman II, Tsuang MT. Fifty years of the Nuremberg Code: A time for retrospection and introspection. American Journal of Medical Genetics, Neuropsychiatric Genetics 1997;74:345-347. [Editorial].

44. Faraone SV, Biederman J. Depression: A Family Affair. Lancet 1998;351:158. [Invited Editorial].

45. Tsuang MT, Faraone SV. Schizophrenia In: Jameson L, editor. Principles of Molecular Medicine. Totowa, NJ:Humana Press;1998.

46. Tsuang MT, Stone WS, Faraone SV. Overview for treatment for schizotypal and schizoid personality disorders: present and future. NOOS Aggiornamenti in Psichiatria, 1998, 3, 201-216.

47. Tsuang MT, Faraone SV. The concept of target features in schizophrenia research. Acta Psychiatrica Scandinavica Supplement 1999;395:2-11.

48. Faraone SV, Biederman J. Neurobiology of Attention Deficit Hyperactivity Disorder. In: Charney DS, Nestler EJ, Bunney BS, editors. Neurobiology of Mental Illness. New York: Oxford University Press;1999:788-801.

49. Tsuang D., Faraone SV, Tsuang MT. Psychiatric Genetic Counseling. In: Watson SJ, editor. Psychopharmacology: The Fourth Generation of Progress-Version 2, CD ROM. New York: Lipponcott and Williams;1998. http://www.acnp.org/citations/GN401000181

50. Tsuang MT, Seidman, LJ, Faraone SV. New Approaches to the Genetics of schizophrenia. In: Gattaz WF, editor. The Search for the Causes of Schizophrenia. Springer-Verlag:1999, 191-207.

51. Faraone SV. Depression in youth: Trends in diagnosis. In: Maj M, editor. Depressive Disorders, World Psychiatric Association Series: Evidence & Experience in Psychiatry. NY: John Wiley & Sons;1999, pp269-271. [Invited Commentary]

52. Spencer T, Biederman J, Wilens TE, Faraone SV. Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis. Journal of Clinical Psychiatry 1998;59:59-68.

53. Faraone SV, Biederman J. Neurobiology of Attention Deficit Hyperactivity Disorder. Biological Psychiatry 1998;44:951-8. [Invited Review]

54. Tsuang MT, Stone WS, Faraone SV. Schizophrenia: Epidemiology and Genetic Studies. Italian Journal of Psychiatry and Behavioural Sciences 1998;8:59-71. [Invited Review]

55. Tsuang MT, Faraone SV, Green AI. Schizophrenia and other psychotic disorders. In: Armand M. Nicholi J, editors. The Harvard Guide to Psychiatry. Cambridge, MA: Harvard University Press; 1999.

56. Tsuang MT, Stone BS, Faraone SV. Schizophrenia: A review of genetic studies. Harvard Review of Psychiatry. 1999;7:185-207.

57. Faraone SV, Doyle A. Genetic influences on attention deficit hyperactivity disorder. Current Psychiatry Reports 2000;2:143-146. [Invited Review]

58. Tsuang MT, Faraone SV. The future of psychiatric genetics. Current Psychiatry Reports 2000;2:133-136.

59. Tsuang MT, Stone WS, Faraone SV. Conceptualization of the liability for schizophrenia: Clinical implications. Dialogues in Clinical Neuroscience 2000;1:153-164.

60. Faraone SV. Attention deficit hyperactivity disorder in adults: Implications for theories of diagnosis. Current Directions in Psychological Science 2000;9:33-36. [Invited Review].

61. The ADHD Molecular Genetics Network. Collaborative possibilities for molecular genetic studies of attention deficit hyperactivity disorder: Report from an international conference. American Journal of Medical Genetics (Neuropsychiatric Genetics) 2000;96: 251-257. (S.V. Faraone, Principal Investigator).

62. Chen WJ, Faraone SV. Sustained attention deficits as markers of genetic susceptibility to schizophrenia. American Journal of Medical Genetics 2000:97;52-57.

63. Tsuang MT, Faraone SV. The frustrating search for schizophrenia genes. American Journal of Medical Genetics 2000;97:1-3. [Editorial].

64. Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, Doyle A. Attention Deficit Hyperactivity Disorder in Adults: An Overview. Biological Psychiatry 2000;48:9-20. [Invited Review].

65. Tsuang MT, and Faraone SV. The genetic epidemiology of bipolar disorder. In: Marneros A, Angst J, eds. Bipolar Disorders: 100 Years After Manic-Depressive Insanity. Zurich: Kluwer Academic; 2000.

66. Tsuang M, Stone WS, and Faraone SV. Schizoaffective and schizotypal disorders. In: Gelder MG, Lopez-Ibor JJ, Andreasen N, ed^eds. New Oxford Textbook of Psychiatry. 1 vol. Oxford, UK: Oxford University Press, Inc.; 2000:4.3.8.

67. Faraone SV. Is attention deficit hyperactivity disorder genetically heterogeneous? Journal of the American Academy of Child and Adolescent Psychiatry 2000;39:1455-1457. [Invited Column].

68. Biederman J, Mick E, Faraone SV, Spencer T, Wilens TE, and Wozniak J. Pediatric mania: a developmental subtype of bipolar disorder? Biol Psychiatry 2000;48:458-66.

69. Mick E, Biederman J, and Faraone SV. Comment on Lambert and Hartsough (1998). Journal of Learning Disabilities 2000;33:314-316.

70. Cattalani M, Faraone SV, Tsuang MT. Newer-Generation psychotropic medications: A current review. Best Practice of Medicine 2000; http://praxis.md/bpm.

71. Faraone SV, and Biederman J. Nature, nurture, and attention deficit hyperactivity disorder. Developmental Review 2000;20:568-581. [Invited Commentary].

72. Faraone SV. The Genetics of Attention Deficit Hyperactivity Disorder. Child and Adolescent Psychopharmacology News, 2001, 5 (6) 7-10. [Invited Review]

73. Faraone SV, Green AI, Seidman LJ, Tsuang MT. "Schizotaxia": Clinical Implications and New Directions for Research. Schizophrenia Bulletin, 2001, 27: 1-18.

74. Faraone SV, Biederman J. ADHD: Disorder or discipline problem? Science 2001;291:1488-1489.

75. Faraone SV, Doyle A. The nature and heritability of attention deficit hyperactivity disorder. In: Todd R, editor. Child and Adolescent Psychiatric Clinics of North America 2001 Apr;10(2):299-316.

76. Nimgaonkar, VL, Faraone, SV, Lerer, B, Mallet, J, Sherrington, R, Maier, W. Impact of overlapping recruitment on psychiatric genetic studies. American Journal of Medical Genetics, Neuropsychiatric Genetics, 2001; 105:139-140. [Editorial Commentary]

77. Faraone SV, Tsuang MT. Adult attention deficit hyperactivity disorder. Current Psychiatry Reports 2001;3:129-130.

78. Tsuang DW, Faraone SV, Tsuang MT. Genetic counseling for psychiatric disorders. Current Psychiatry Reports 2001;3:138-143.

79. Tsuang MT, Stone WS, Faraone SV. Genes, environment and schizophrenia. British Journal of Psychiatry Suppl 2001;40:s18-24.

80. The ADHD Molecular Genetics Network. Report from the Second International Meeting of the Attention Deficit Hyperactivity Disorder Molecular Genetics Network. American Journal of Medical Genetics 2001;105(3):255-258 (SV Faraone, Principal Investigator)

81. Levinson DF, Reich T, Todd RD, Weissman MM, Crowe RR, DeLisi L, Faraone SV, Folstein S, Pelias MK, Pulver AE, Silverman JM. Protecting the privacy of family members in research. Journal of the American Medical Association 2001;285:1960-1.

82. Biederman J, Spencer TJ, Wozniak J, Faraone SV, Mick E. Attention-Deficit/Hyperactivity Disorder and Pediatric Onset Bipolar Disorder. Economics of Neuroscience: T.E.N. 2001; 3:45-48.

83. Tsuang MT, Stone WS, Tarbox SI, Faraone, SV. Genetic Aspects of Schizophrenia. In Psychiatry Hightlights 2001-2002. M Lader (Ed). London: Health Press, 2002

84. Faraone SV. Report from the third international meeting of the Attention-Deficit Hyperactivity Disorder Molecular Genetics Network. Am J Med Genet. 2002 Apr 8;114(3):272-6.

85. Taylor L, Faraone SV, Tsuang MT. Family, twin, and adoption studies of bipolar disease. Curr Psychiatry Rep. 2002 Mar;4(2):130-3.

86. Doyle AE, Faraone SV. Familial links between attention deficit hyperactivity disorder, conduct disorder, and bipolar disorder. Curr Psychiatry Rep. 2002 Mar;4(2):146-52.

87. Faraone SV. Defining genetically meaningful classes of psychopathology. In: Helzer J and Hudziak, J, editors. Defining Psychopathology in the 21st Century. Washington, DC: American Psychiatric Press, 2002. [Invited Review]

88. Tsuang DW, Faraone SV, and Tsuang MT. Implications of Psychiatric Genetics and the Use of Genetic Counseling. Directions in Psychiatry 2002;22:155-164.

89. Faraone SV, Brown CH, Glatt SJ, Tsuang MT. Preventing schizophrenia and psychotic behaviour: definitions and methodological issues. Can J Psychiatry. 2002 Aug;47(6):527-37.

90. Tsuang MT, Stone WS, Faraone SV. Understanding the predisposition to schizophrenia: toward intervention and prevention. Can J Psychiatry. 2002 Aug;47(6):518-26.

91. Tsuang MT, Faraone SV. Diagnostic concepts and the prevention of schizophrenia.Can J Psychiatry. 2002 Aug;47(6):515-7.

92. Tsuang MT, Taylor L, Faraone SV. Psychiatric genetics. Future and prospects. Methods Mol Med. 2003;77:251-65.

93. Faraone SV, Taylor L, Tsuang MT. (2002) The molecular genetics of schizophrenia: an emerging consensus. Exp. Rev. Mol. Med. 23 May, ttp://www.expertreviews.org/02004751h.htm [Invited Review]

94. Faraone SV. Review of “Stimulant Drugs and ADHD: Basic and Clinical Neuroscience”. Solanto, MV., Arnsten, AFT and Castellanos, FX editors. Journal of Nervous and Mental Disease 2002, 190, 203-204. [Invited Book Review].

95. Faraone SV, Tsuang, D.W., Tsuang MT. Methods in Psychiatric Genetics. In: Tohen M, and Tsuang MT, editors. Textbook in Psychiatric Epidemiology (2nd Edition). NY: John Wiley; 2002. [Invited Review]

96. Tsuang MT, Taylor L, and Faraone SV. Psychiatric genetics. Future and prospects. Methods Mol Med 2003;77:251-65.

97. Faraone SV, Doyle A. Attention deficit hyperactivity disorder. In: Houston M, editor. Principles and Practice of Medical Genetics. Fourth ed. Philadelphia, PA: W.B. Saunders, 2002.

98. Faraone SV. Heterogeneity of Bipolar Disorder: Does Childhood Onset Make a Difference?. In: Maj M, editor. Bipolar Disorders, World Psychiatric Association Series: Evidence & Experience in Psychiatry. NY: John Wiley & Sons; 2002. [Invited Editorial Commentary]

99. Faraone SV & Biederman, J. Pathophysiology of ADHD, In: Davis K, Charney D, Coyle JT, and Nemeroff C., editors. Psychopharmacology: The Fifth Generation of Progress-Version 2. New York: Lipponcott, Williams, and Wilkens 2002. [Invited Review]

100. Biederman J, Faraone SV. Current concepts on the neurobiology of Attention-Deficit/Hyperactivity Disorder. J Atten Disord. 2002;6 Suppl 1:S7-16.

101. Faraone SV. Attention Deficit Hyperactivity Disorder. In Robinson, R, editor, Encyclopedia of Genetics, New York: Macmillan, vol 1, pp 39-42, 2003 [Invited Review]

102. Faraone SV, Taylor L, Tsuang M. The molecular genetics of schizophrenia: an emerging consensus. Expert Rev Mol Med. 2002 May 23;4:1-13. [Invited Review]

103. Faraone SV, Biederman J, Spencer TJ. New Data About Stimulant Effects on Growth. Hasbrouck Heights, NJ: Veritas Institute for Medical Education, Inc; 2003. ADHD Research Report: Special Edition.

104. Tsuang MT, Stone WS, Gamma F, Faraone SV. Schizotaxia: current status and future directions. Curr Psychiatry Rep. 2003 Apr;5(2):128-34.

105. Faraone SV, Glatt SJ, Tsuang MT. The genetics of pediatric-onset bipolar disorder.Biol Psychiatry. 2003 Jun 1;53(11):970-7.

106. Faraone SV. Report from the 4th international meeting of the attention deficit hyperactivity disorder molecular genetics network.Am J Med Genet. 2003 Aug 15;121B(1):55-9.

107. Biederman J, Mick E, Faraone SV, Spencer T, Wilens TE, Wozniak J. Current concepts in the validity, diagnosis and treatment of paediatric bipolar disorder. Int J Neuropsychopharmacol. 2003 Sep;6(3):293-300.

108. Tsuang MT, Stone WS, Tarbox SI, Faraone SV. Implications of schizotaxia for the prevention of schizophrenia. In Grispini A, ed. Preventive strategies for schizophrenic disorders: Perspective, opportunities and limits. Rome, Italy, Giovanni Fioriti Editore S.r.l., 2003

109. Faraone, SV and Tsuang, MT. Heterogeneity and the Genetics of Bipolar Disorder, Seminars in Medical Genetics, Am J Med Genet 2003;119B:1 [Invited Editorial Commentary]

110. Faraone, SV Understanding the Effect Size of ADHD Medications: Implications for Clinical Care, Medscape Psychiatry & Mental Health 8(2), 2003

111. Tsuang MT, Taylor L, Faraone SV. An overview of the genetics of psychotic mood disorders.J Psychiatr Res. 2004 Jan-Feb;38(1):3-15.

112. Brown, CH and Faraone SV, Prevention of Schizophrenia and Psychotic Behavior: Definitions and Methodologic Issues In SV. Stone WS, Faraone SV, Tsuang MT, eds. Early Clinical Intervention and Prevention in Schizophrenia. Totowa, NJ; The Humana Press, Inc.2004.

113. Faraone SV, Glatt, SJ and Taylor, L. The Genetic Basis of Schizophrenia. In SV. Stone WS, Faraone SV, Tsuang MT, eds. Early Clinical Intervention and Prevention in Schizophrenia. Totowa, NJ; The Humana Press, Inc. 2004.

114. Faraone SV. Attention deficit hyperactivity disorder in adults: Implications for theories of diagnosis. In TF Oltmanns and RE Emery (Eds.) Current Directions in Abnormal Psychology 2004 pp 145-151.

115. Biederman J. and Faraone SV. The Massachusetts General Hospital studies of gender influences on attention-deficit/hyperactivity disorder in youth and relatives. Psychiatr Clin North Am, 2004;27:225-32.

116. Faraone SV. Genetics of adult attention-deficit/hyperactivity disorder. In T. Spencer (Ed), Psychiatr Clin North Am, Phladelphia PA; Saunder Press. 2004 (Vol 27, pp 303-21).

117. Mick E, Faraone SV, Biederman J. Age-dependent expression of attention-deficit/hyperactivity disorder symptoms. Psychiatr Clin North Am, 2004;27:215-24.

118. Abdolmaleky HM, Smith CL, Faraone SV, Shafa R, Stone W, Glatt SJ, Tsuang MT. Methylomics in psychiatry: Modulation of gene-environment interactions may be through DNA methylation. Am J Med Genet 2004; May 15; 127B(1):51-9.

119. Faraone SV, Biederman J. Neurobiology of Attention Deficit Hyperactivity Disorder. In: Charney DS, Nestler EJ, Bunney BS, editors. Neurobiology of Mental Illness. New York: Oxford University Press;2004:979-999.

120. Tsuang MT, Bar JL, Stone WS, Faraone SV. Gene-environment interactions in mental disorders. World Psychiatry; 2004; 3:73-83.

121. Wilens T, Faraone S, Biederman J. Attention-deficit/hyperactivity disorder in Adults.. JAMA 2004 Aug 4;292(5):619-23. [Invited Review]

122. Faraone SV and Biederman, J. Attention Deficit Hyperactivity Disorder in Adults: Implications for Primary Care Practitioners [Editorial] Primary Psychiatry 2004;11; 26-27.

123. Faraone, SV The Scientific Foundation for Understanding Attention-Deficit/Hyperactivity Disorder as a Valid Psychiatric Disorder, European Child and Adolescent Psychiatry. 2005; 14:1-10.

124. Willcut EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. Validity of the executive function theory of ADHD: A meta-analytic review. Biological Psychiatry 2005;57:1336-1346.

125. Biederman, J. and Faraone, S.V. Attention Deficit Hyperactivity Disorder, Lancet, 2005 Jul 16-22;366(9481):237-48. [Invited Review]

126. Mick E, Faraone SV, Biederman J, Spencer T. The Course and Outcome of ADHD. Primary Psychiatry (In Press).

127. Faraone SV. Etiology and Pathophysiology of Adult Attention Deficit Hyperactivity Disorder Primary Psychiatry (In Press).

128. Biederman J and Faraone SV. Attention-deficit/hyperactivity disorder: A Worldwide Concern. Journal of Nervous and Mental Disease. [Invited Editorial Commentary] (In Press).

129. Faraone, SV, Improving mental health care for children and adolescents: a role for prevention science, World Psychiatry, in press. [Invited Editorial Commentary]

Books 1. Tsuang MT, Faraone SV. The Genetics of Mood Disorders, Baltimore, MD: Johns Hopkins; 1990.

2. Tsuang MT, Faraone SV. Schizophrenia: The Facts, Oxford,UK: Oxford University Press; 1997.

3. Faraone SV, Tsuang, D, Tsuang MT. Genetics and Mental Disorders: A Guide for Students, Clinicians, and Researchers. New York, NY: Guilford;1999.

4. Faraone, S.V. Straight Talk About Your Child’s Mental Health: What To Do When Something Seems Wrong. New York, NY: Guilford, 2003

5. Stone WS, Faraone SV, Tsuang MT, eds. Early Clinical Intervention and Prevention in Schizophrenia. Totowa, NJ; The Humana Press, Inc. 2004.

cv-stephenvfaraone - bio · guest editor, seminars in medical genetics, schizophrenia issue 1999...

Documents